ADR,SEQ,PT,HLT,HLGT,SOC_ABBREV,FATAL_YN
1,1,Cardiac arrest,Ventricular arrhythmias and cardiac arrest,Cardiac arrhythmias,Card,Y
2,1,Jaundice,Cholestasis and jaundice,Hepatic and hepatobiliary disorders,Hepat,N
3,1,Hepatic enzyme increased,Hepatobiliary function diagnostic procedures,Hepatobiliary investigations,Inv,N
3,2,Hepatitis,Hepatocellular damage and hepatitis NEC,Hepatic and hepatobiliary disorders,Hepat,N
3,3,Liver function test abnormal,Hepatobiliary function diagnostic procedures,Hepatobiliary investigations,Inv,N
4,1,Abdominal pain upper,Gastrointestinal and abdominal pains (excl oral and throat),Gastrointestinal signs and symptoms,Gastr,N
4,2,Hepatic enzyme increased,Hepatobiliary function diagnostic procedures,Hepatobiliary investigations,Inv,N
4,3,Hepatitis,Hepatocellular damage and hepatitis NEC,Hepatic and hepatobiliary disorders,Hepat,N
4,4,Ill-defined disorder,General signs and symptoms NEC,General system disorders NEC,Genrl,N
4,5,Liver function test abnormal,Hepatobiliary function diagnostic procedures,Hepatobiliary investigations,Inv,N
5,1,Hepatic enzyme increased,Hepatobiliary function diagnostic procedures,Hepatobiliary investigations,Inv,N
5,2,Hepatitis,Hepatocellular damage and hepatitis NEC,Hepatic and hepatobiliary disorders,Hepat,N
5,3,Liver function test abnormal,Hepatobiliary function diagnostic procedures,Hepatobiliary investigations,Inv,N
6,1,Oedema peripheral,Oedema NEC,General system disorders NEC,Genrl,N
6,2,Rash erythematous,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
7,1,Abdominal pain,Gastrointestinal and abdominal pains (excl oral and throat),Gastrointestinal signs and symptoms,Gastr,N
7,2,Hepatic function abnormal,Hepatic enzymes and function abnormalities,Hepatic and hepatobiliary disorders,Hepat,N
7,3,Jaundice,Cholestasis and jaundice,Hepatic and hepatobiliary disorders,Hepat,N
7,4,Malaise,Asthenic conditions,General system disorders NEC,Genrl,N
7,5,Nausea,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
7,6,Vomiting,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
8,1,Diarrhoea,Diarrhoea (excl infective),Gastrointestinal motility and defaecation conditions,Gastr,N
8,2,Malaise,Asthenic conditions,General system disorders NEC,Genrl,N
9,1,Fatigue,Asthenic conditions,General system disorders NEC,Genrl,N
9,2,Mucosal inflammation,Mucosal findings abnormal,General system disorders NEC,Genrl,N
9,3,Palmar-plantar erythrodysaesthesia syndrome,Dermatitis ascribed to specific agent,Epidermal and dermal conditions,Skin,N
10,1,Hyponatraemia,Sodium imbalance,Electrolyte and fluid balance conditions,Metab,N
10,2,Seizure,Seizures and seizure disorders NEC,Seizures (incl subtypes),Nerv,N
11,1,Blindness,Visual impairment and blindness (excl colour blindness),Vision disorders,Eye,N
11,2,Brain oedema,Increased intracranial pressure disorders,Increased intracranial pressure and hydrocephalus,Nerv,N
11,3,Cerebral infarction,Central nervous system haemorrhages and cerebrovascular accidents,Central nervous system vascular disorders,Nerv,N
11,4,Epilepsy,Seizures and seizure disorders NEC,Seizures (incl subtypes),Nerv,N
11,5,Headache,Headaches NEC,Headaches,Nerv,N
11,6,Hypertension,Vascular hypertensive disorders NEC,Vascular hypertensive disorders,Vasc,N
11,7,Posterior reversible encephalopathy syndrome,Encephalopathies NEC,Encephalopathies,Nerv,N
12,1,Hypertension,Vascular hypertensive disorders NEC,Vascular hypertensive disorders,Vasc,N
13,1,Hepatic enzyme increased,Hepatobiliary function diagnostic procedures,Hepatobiliary investigations,Inv,N
14,1,Blood bilirubin increased,Hepatobiliary function diagnostic procedures,Hepatobiliary investigations,Inv,N
14,2,Hypertension,Vascular hypertensive disorders NEC,Vascular hypertensive disorders,Vasc,N
15,1,Alanine aminotransferase increased,Hepatobiliary function diagnostic procedures,Hepatobiliary investigations,Inv,N
15,2,Blood alkaline phosphatase increased,Tissue enzyme analyses NEC,Enzyme investigations NEC,Inv,N
15,3,Blood bilirubin increased,Hepatobiliary function diagnostic procedures,Hepatobiliary investigations,Inv,N
15,4,Hepatic enzyme increased,Hepatobiliary function diagnostic procedures,Hepatobiliary investigations,Inv,N
16,1,Acute kidney injury,Renal failure and impairment,Renal disorders (excl nephropathies),Renal,N
16,2,Creatinine renal clearance decreased,Renal function analyses,Renal and urinary tract investigations and urinalyses,Inv,N
16,3,Hypertension,Vascular hypertensive disorders NEC,Vascular hypertensive disorders,Vasc,N
17,1,Rash erythematous,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
18,1,Retinal detachment,"Retinal structural change, deposit and degeneration","Ocular structural change, deposit and degeneration NEC",Eye,N
19,1,Circulatory collapse,Circulatory collapse and shock,Decreased and nonspecific blood pressure disorders and shock,Vasc,N
20,1,Cerebrovascular accident,Central nervous system haemorrhages and cerebrovascular accidents,Central nervous system vascular disorders,Nerv,N
21,1,Ventricular tachycardia,Ventricular arrhythmias and cardiac arrest,Cardiac arrhythmias,Card,N
22,1,Disease progression,General signs and symptoms NEC,General system disorders NEC,Genrl,Y
22,2,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
23,1,Gastrointestinal perforation,"Gastrointestinal ulcers and perforation, site unspecified",Gastrointestinal ulceration and perforation,Gastr,N
24,1,Confusional state,Confusion and disorientation,Deliria (incl confusion),Psych,N
24,2,Posterior reversible encephalopathy syndrome,Encephalopathies NEC,Encephalopathies,Nerv,Y
25,1,Blood bilirubin increased,Hepatobiliary function diagnostic procedures,Hepatobiliary investigations,Inv,N
25,2,Hypothyroidism,Thyroid hypofunction disorders,Thyroid gland disorders,Endo,N
25,3,Jaundice,Cholestasis and jaundice,Hepatic and hepatobiliary disorders,Hepat,N
25,4,Liver function test increased,Hepatobiliary function diagnostic procedures,Hepatobiliary investigations,Inv,N
25,5,Neutropenia,Neutropenias,White blood cell disorders,Blood,N
26,1,Cardiac failure,Heart failures NEC,Heart failures,Card,N
27,1,Alanine aminotransferase increased,Hepatobiliary function diagnostic procedures,Hepatobiliary investigations,Inv,N
27,2,Blood creatinine increased,Renal function analyses,Renal and urinary tract investigations and urinalyses,Inv,N
27,3,Glomerular filtration rate decreased,Renal function analyses,Renal and urinary tract investigations and urinalyses,Inv,N
27,4,Hepatotoxicity,Hepatocellular damage and hepatitis NEC,Hepatic and hepatobiliary disorders,Hepat,N
28,1,Blood bilirubin increased,Hepatobiliary function diagnostic procedures,Hepatobiliary investigations,Inv,N
28,2,Liver function test increased,Hepatobiliary function diagnostic procedures,Hepatobiliary investigations,Inv,N
28,3,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
29,1,Alanine aminotransferase increased,Hepatobiliary function diagnostic procedures,Hepatobiliary investigations,Inv,N
29,2,Blood albumin decreased,Protein analyses NEC,Protein and chemistry analyses NEC,Inv,N
29,3,Blood alkaline phosphatase increased,Tissue enzyme analyses NEC,Enzyme investigations NEC,Inv,N
29,4,Blood creatinine increased,Renal function analyses,Renal and urinary tract investigations and urinalyses,Inv,N
29,5,Blood urea increased,Renal function analyses,Renal and urinary tract investigations and urinalyses,Inv,N
29,6,Decreased appetite,Appetite disorders,Appetite and general nutritional disorders,Metab,N
29,7,Hepatic enzyme increased,Hepatobiliary function diagnostic procedures,Hepatobiliary investigations,Inv,N
29,8,Jaundice,Cholestasis and jaundice,Hepatic and hepatobiliary disorders,Hepat,N
29,9,Lethargy,Disturbances in consciousness NEC,Neurological disorders NEC,Nerv,N
29,10,Mobility decreased,Musculoskeletal and connective tissue conditions NEC,Musculoskeletal and connective tissue disorders NEC,Musc,N
29,11,Nausea,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
29,12,Renal failure,Renal failure and impairment,Renal disorders (excl nephropathies),Renal,N
29,13,Vomiting,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
30,1,Back pain,Musculoskeletal and connective tissue pain and discomfort,Musculoskeletal and connective tissue disorders NEC,Musc,N
30,2,Jaundice,Cholestasis and jaundice,Hepatic and hepatobiliary disorders,Hepat,N
30,3,Lethargy,Disturbances in consciousness NEC,Neurological disorders NEC,Nerv,N
30,4,Liver function test abnormal,Hepatobiliary function diagnostic procedures,Hepatobiliary investigations,Inv,N
31,1,Balance disorder,Coordination and balance disturbances,Neurological disorders NEC,Nerv,N
31,2,Cerebral haematoma,Central nervous system haemorrhages and cerebrovascular accidents,Central nervous system vascular disorders,Nerv,N
31,3,Confusional state,Confusion and disorientation,Deliria (incl confusion),Psych,N
31,4,Headache,Headaches NEC,Headaches,Nerv,N
31,5,Hypertension,Vascular hypertensive disorders NEC,Vascular hypertensive disorders,Vasc,N
32,1,Alanine aminotransferase increased,Hepatobiliary function diagnostic procedures,Hepatobiliary investigations,Inv,N
32,2,Drug interaction,Interactions,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
33,1,Transient ischaemic attack,Transient cerebrovascular events,Central nervous system vascular disorders,Nerv,N
34,1,Liver function test abnormal,Hepatobiliary function diagnostic procedures,Hepatobiliary investigations,Inv,N
35,1,Retinal detachment,"Retinal structural change, deposit and degeneration","Ocular structural change, deposit and degeneration NEC",Eye,N
36,1,Blood bilirubin increased,Hepatobiliary function diagnostic procedures,Hepatobiliary investigations,Inv,N
36,2,Decreased appetite,Appetite disorders,Appetite and general nutritional disorders,Metab,N
36,3,Drug-induced liver injury,Hepatocellular damage and hepatitis NEC,Hepatic and hepatobiliary disorders,Hepat,N
36,4,Hepatic enzyme increased,Hepatobiliary function diagnostic procedures,Hepatobiliary investigations,Inv,N
36,5,Jaundice,Cholestasis and jaundice,Hepatic and hepatobiliary disorders,Hepat,N
36,6,Liver disorder,Hepatic and hepatobiliary disorders NEC,Hepatic and hepatobiliary disorders,Hepat,N
36,7,Nausea,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
37,1,Faeces pale,Faecal abnormalities NEC,Gastrointestinal signs and symptoms,Gastr,N
37,2,Fatigue,Asthenic conditions,General system disorders NEC,Genrl,N
37,3,Hepatotoxicity,Hepatocellular damage and hepatitis NEC,Hepatic and hepatobiliary disorders,Hepat,N
37,4,Liver function test abnormal,Hepatobiliary function diagnostic procedures,Hepatobiliary investigations,Inv,N
37,5,Nausea,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
37,6,Yellow skin,Dermal and epidermal conditions NEC,Epidermal and dermal conditions,Skin,N
38,1,Alanine aminotransferase increased,Hepatobiliary function diagnostic procedures,Hepatobiliary investigations,Inv,N
38,2,Aspartate aminotransferase increased,Hepatobiliary function diagnostic procedures,Hepatobiliary investigations,Inv,N
38,3,Hepatotoxicity,Hepatocellular damage and hepatitis NEC,Hepatic and hepatobiliary disorders,Hepat,N
39,1,Blood pressure increased,Vascular tests NEC (incl blood pressure),Cardiac and vascular investigations (excl enzyme tests),Inv,N
39,2,Dyspnoea exertional,Breathing abnormalities,Respiratory disorders NEC,Resp,N
39,3,Ejection fraction decreased,Cardiac function diagnostic procedures,Cardiac and vascular investigations (excl enzyme tests),Inv,N
39,4,Hypertension,Vascular hypertensive disorders NEC,Vascular hypertensive disorders,Vasc,N
39,5,Ventricular hypokinesia,Myocardial disorders NEC,Myocardial disorders,Card,N
40,1,Dehydration,Total fluid volume decreased,Electrolyte and fluid balance conditions,Metab,N
40,2,Diarrhoea,Diarrhoea (excl infective),Gastrointestinal motility and defaecation conditions,Gastr,N
41,1,Myelosuppression,Marrow depression and hypoplastic anaemias,Anaemias nonhaemolytic and marrow depression,Blood,N
41,2,Neutrophil count decreased,White blood cell analyses,Haematology investigations (incl blood groups),Inv,N
42,1,Blood pressure increased,Vascular tests NEC (incl blood pressure),Cardiac and vascular investigations (excl enzyme tests),Inv,N
42,2,Ejection fraction decreased,Cardiac function diagnostic procedures,Cardiac and vascular investigations (excl enzyme tests),Inv,N
43,1,Acute hepatic failure,Hepatic failure and associated disorders,Hepatic and hepatobiliary disorders,Hepat,N
44,1,Haemoperitoneum,Peritoneal and retroperitoneal haemorrhages,Peritoneal and retroperitoneal conditions,Gastr,N
45,1,Alanine aminotransferase increased,Hepatobiliary function diagnostic procedures,Hepatobiliary investigations,Inv,N
45,2,Aspartate aminotransferase increased,Hepatobiliary function diagnostic procedures,Hepatobiliary investigations,Inv,N
45,3,Cough,Coughing and associated symptoms,Respiratory disorders NEC,Resp,N
45,4,Diarrhoea,Diarrhoea (excl infective),Gastrointestinal motility and defaecation conditions,Gastr,N
45,5,Disease progression,General signs and symptoms NEC,General system disorders NEC,Genrl,N
45,6,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
45,7,Hypertension,Vascular hypertensive disorders NEC,Vascular hypertensive disorders,Vasc,N
45,8,Lymphadenopathy,Lymphatic system disorders NEC,"Spleen, lymphatic and reticuloendothelial system disorders",Blood,N
45,9,Pulmonary embolism,Pulmonary thrombotic and embolic conditions,Pulmonary vascular disorders,Resp,N
46,1,Epistaxis,Nasal disorders NEC,Upper respiratory tract disorders (excl infections),Resp,N
46,2,Liver function test abnormal,Hepatobiliary function diagnostic procedures,Hepatobiliary investigations,Inv,N
46,3,Platelet count decreased,Platelet analyses,Haematology investigations (incl blood groups),Inv,N
47,1,Condition aggravated,General signs and symptoms NEC,General system disorders NEC,Genrl,N
47,2,Liver function test abnormal,Hepatobiliary function diagnostic procedures,Hepatobiliary investigations,Inv,N
48,1,Abdominal pain,Gastrointestinal and abdominal pains (excl oral and throat),Gastrointestinal signs and symptoms,Gastr,N
48,2,Diarrhoea,Diarrhoea (excl infective),Gastrointestinal motility and defaecation conditions,Gastr,N
48,3,Intestinal obstruction,Gastrointestinal stenosis and obstruction NEC,Gastrointestinal stenosis and obstruction,Gastr,N
48,4,Thrombosis mesenteric vessel,Gastrointestinal vascular occlusion and infarction,Gastrointestinal vascular conditions,Gastr,N
48,5,Thrombotic microangiopathy,Coagulopathies,Coagulopathies and bleeding diatheses (excl thrombocytopenic),Blood,Y
49,1,Abdominal pain lower,Gastrointestinal and abdominal pains (excl oral and throat),Gastrointestinal signs and symptoms,Gastr,N
49,2,Gastrointestinal perforation,"Gastrointestinal ulcers and perforation, site unspecified",Gastrointestinal ulceration and perforation,Gastr,N
50,1,Dyspnoea,Breathing abnormalities,Respiratory disorders NEC,Resp,N
50,2,Exercise tolerance decreased,General signs and symptoms NEC,General system disorders NEC,Genrl,N
50,3,Insomnia,Disturbances in initiating and maintaining sleep,Sleep disorders and disturbances,Psych,N
51,1,Blood pressure increased,Vascular tests NEC (incl blood pressure),Cardiac and vascular investigations (excl enzyme tests),Inv,N
51,2,Liver disorder,Hepatic and hepatobiliary disorders NEC,Hepatic and hepatobiliary disorders,Hepat,N
52,1,Aortic aneurysm rupture,Aortic aneurysms and dissections,Aneurysms and artery dissections,Vasc,N
52,2,Syncope,Disturbances in consciousness NEC,Neurological disorders NEC,Nerv,N
53,1,Anaemia,Anaemias NEC,Anaemias nonhaemolytic and marrow depression,Blood,N
53,2,Lower respiratory tract infection,Lower respiratory tract and lung infections,Infections - pathogen unspecified,Infec,N
54,1,Adverse drug reaction,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
54,2,Dysgeusia,Sensory abnormalities NEC,Neurological disorders NEC,Nerv,N
54,3,Fatigue,Asthenic conditions,General system disorders NEC,Genrl,N
54,4,Metastases to lung,Metastases to specified sites,Metastases,Neopl,N
54,5,Renal cell carcinoma,Renal neoplasms malignant,Renal and urinary tract neoplasms malignant and unspecified,Neopl,N
55,1,Abdominal pain,Gastrointestinal and abdominal pains (excl oral and throat),Gastrointestinal signs and symptoms,Gastr,N
55,2,Duodenal ulcer perforation,Duodenal ulcers and perforation,Gastrointestinal ulceration and perforation,Gastr,N
56,1,Cerebral infarction,Central nervous system haemorrhages and cerebrovascular accidents,Central nervous system vascular disorders,Nerv,N
57,1,Fistula,Soft tissue disorders NEC,Musculoskeletal and connective tissue disorders NEC,Musc,N
57,2,Intestinal fistula,Gastrointestinal fistulae,Gastrointestinal conditions NEC,Gastr,N
57,3,Sepsis,"Sepsis, bacteraemia, viraemia and fungaemia NEC",Infections - pathogen unspecified,Infec,Y
58,1,Abdominal distension,"Flatulence, bloating and distension",Gastrointestinal signs and symptoms,Gastr,N
58,2,Aerophagia,"Flatulence, bloating and distension",Gastrointestinal signs and symptoms,Gastr,N
58,3,Dry mouth,Oral dryness and saliva altered,Salivary gland conditions,Gastr,N
58,4,Flatulence,"Flatulence, bloating and distension",Gastrointestinal signs and symptoms,Gastr,N
58,5,Salivary hypersecretion,Oral dryness and saliva altered,Salivary gland conditions,Gastr,N
59,1,Liver function test increased,Hepatobiliary function diagnostic procedures,Hepatobiliary investigations,Inv,N
60,1,Gynaecomastia,Breast disorders NEC,Breast disorders,Repro,N
61,1,Aortic dissection,Aortic aneurysms and dissections,Aneurysms and artery dissections,Vasc,N
62,1,Tumour haemorrhage,Oncologic complications and emergencies,Neoplasm related morbidities,Neopl,N
63,1,Diarrhoea,Diarrhoea (excl infective),Gastrointestinal motility and defaecation conditions,Gastr,N
63,2,Hair colour changes,Pilar disorders NEC,Skin appendage conditions,Skin,N
63,3,Hypertension,Vascular hypertensive disorders NEC,Vascular hypertensive disorders,Vasc,N
64,1,Pneumothorax,Pneumothorax and pleural effusions NEC,Pleural disorders,Resp,N
65,1,Decreased appetite,Appetite disorders,Appetite and general nutritional disorders,Metab,N
65,2,Fatigue,Asthenic conditions,General system disorders NEC,Genrl,N
65,3,Nausea,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
65,4,Neck pain,Musculoskeletal and connective tissue pain and discomfort,Musculoskeletal and connective tissue disorders NEC,Musc,N
65,5,Oral pain,Oral soft tissue signs and symptoms,Oral soft tissue conditions,Gastr,N
65,6,Osteonecrosis of jaw,Bone disorders NEC,Bone disorders (excl congenital and fractures),Musc,N
65,7,Pain,Pain and discomfort NEC,General system disorders NEC,Genrl,N
65,8,Spinal compression fracture,Spinal fractures and dislocations,Bone and joint injuries,Inj&P,N
65,9,Taste disorder,Sensory abnormalities NEC,Neurological disorders NEC,Nerv,N
66,1,Palmar-plantar erythrodysaesthesia syndrome,Dermatitis ascribed to specific agent,Epidermal and dermal conditions,Skin,N
67,1,Renal infarct,Renal vascular and ischaemic conditions,Renal disorders (excl nephropathies),Renal,N
68,1,Acidosis,Mixed acid-base disorders,Acid-base disorders,Metab,N
68,2,Acute kidney injury,Renal failure and impairment,Renal disorders (excl nephropathies),Renal,Y
68,3,Hypotension,Vascular hypotensive disorders,Decreased and nonspecific blood pressure disorders and shock,Vasc,N
68,4,Nausea,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
68,5,Neutrophilia,Leukocytoses NEC,White blood cell disorders,Blood,N
68,6,Urine output decreased,Urinary tract function analyses NEC,Renal and urinary tract investigations and urinalyses,Inv,N
68,7,Vomiting,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
69,1,Dyspnoea,Breathing abnormalities,Respiratory disorders NEC,Resp,N
69,2,Pleural disorder,Pleural conditions NEC,Pleural disorders,Resp,N
69,3,Pneumothorax,Pneumothorax and pleural effusions NEC,Pleural disorders,Resp,Y
70,1,Alanine aminotransferase increased,Hepatobiliary function diagnostic procedures,Hepatobiliary investigations,Inv,N
70,2,Blood pressure increased,Vascular tests NEC (incl blood pressure),Cardiac and vascular investigations (excl enzyme tests),Inv,N
70,3,Diarrhoea,Diarrhoea (excl infective),Gastrointestinal motility and defaecation conditions,Gastr,N
70,4,Fatigue,Asthenic conditions,General system disorders NEC,Genrl,N
70,5,Hair colour changes,Pilar disorders NEC,Skin appendage conditions,Skin,N
70,6,Hypertension,Vascular hypertensive disorders NEC,Vascular hypertensive disorders,Vasc,N
70,7,Lung disorder,Respiratory tract disorders NEC,Respiratory disorders NEC,Resp,N
70,8,Skin hypopigmentation,Hypopigmentation disorders,Pigmentation disorders,Skin,N
70,9,Urostomy,Ureteric therapeutic procedures,Renal and urinary tract therapeutic procedures,Surg,N
70,10,Vesical fistula,Bladder disorders NEC,Bladder and bladder neck disorders (excl calculi),Renal,N
71,1,Subdural haematoma,Cerebral injuries NEC,Injuries NEC,Inj&P,N
72,1,Blood pressure increased,Vascular tests NEC (incl blood pressure),Cardiac and vascular investigations (excl enzyme tests),Inv,N
72,2,Periorbital oedema,Ocular disorders NEC,Eye disorders NEC,Eye,N
73,1,Alanine aminotransferase increased,Hepatobiliary function diagnostic procedures,Hepatobiliary investigations,Inv,N
74,1,Pleural effusion,Pneumothorax and pleural effusions NEC,Pleural disorders,Resp,N
74,2,Pneumothorax,Pneumothorax and pleural effusions NEC,Pleural disorders,Resp,N
75,1,Liver function test abnormal,Hepatobiliary function diagnostic procedures,Hepatobiliary investigations,Inv,N
75,2,Pulmonary embolism,Pulmonary thrombotic and embolic conditions,Pulmonary vascular disorders,Resp,N
76,1,Atrioventricular block complete,Cardiac conduction disorders,Cardiac arrhythmias,Card,N
77,1,Polycythaemia,Polycythaemia (excl rubra vera),Red blood cell disorders,Blood,N
78,1,Platelet count decreased,Platelet analyses,Haematology investigations (incl blood groups),Inv,N
78,2,Thrombocytopenia,Thrombocytopenias,Platelet disorders,Blood,N
79,1,Alanine aminotransferase increased,Hepatobiliary function diagnostic procedures,Hepatobiliary investigations,Inv,N
79,2,Aspartate aminotransferase increased,Hepatobiliary function diagnostic procedures,Hepatobiliary investigations,Inv,N
79,3,Blood bilirubin increased,Hepatobiliary function diagnostic procedures,Hepatobiliary investigations,Inv,N
79,4,Dyspnoea,Breathing abnormalities,Respiratory disorders NEC,Resp,N
79,5,Hepatotoxicity,Hepatocellular damage and hepatitis NEC,Hepatic and hepatobiliary disorders,Hepat,Y
80,1,Diarrhoea,Diarrhoea (excl infective),Gastrointestinal motility and defaecation conditions,Gastr,N
80,2,Myelosuppression,Marrow depression and hypoplastic anaemias,Anaemias nonhaemolytic and marrow depression,Blood,N
81,1,Hypoaesthesia,Paraesthesias and dysaesthesias,Neurological disorders NEC,Nerv,N
81,2,Neurological symptom,Neurological signs and symptoms NEC,Neurological disorders NEC,Nerv,N
81,3,Sensory disturbance,Sensory abnormalities NEC,Neurological disorders NEC,Nerv,N
82,1,Abdominal distension,"Flatulence, bloating and distension",Gastrointestinal signs and symptoms,Gastr,N
82,2,Cough,Coughing and associated symptoms,Respiratory disorders NEC,Resp,N
82,3,Dyspnoea,Breathing abnormalities,Respiratory disorders NEC,Resp,N
82,4,Fatigue,Asthenic conditions,General system disorders NEC,Genrl,N
82,5,Headache,Headaches NEC,Headaches,Nerv,N
82,6,Retching,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
83,1,Death,Death and sudden death,Fatal outcomes,Genrl,Y
83,2,Lower respiratory tract infection,Lower respiratory tract and lung infections,Infections - pathogen unspecified,Infec,N
83,3,Malaise,Asthenic conditions,General system disorders NEC,Genrl,N
84,1,Loss of consciousness,Disturbances in consciousness NEC,Neurological disorders NEC,Nerv,N
84,2,Posterior reversible encephalopathy syndrome,Encephalopathies NEC,Encephalopathies,Nerv,N
85,1,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
85,2,Fatigue,Asthenic conditions,General system disorders NEC,Genrl,N
85,3,Nausea,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
85,4,Oedema peripheral,Oedema NEC,General system disorders NEC,Genrl,N
85,5,Proteinuria,Urinary abnormalities,Urinary tract signs and symptoms,Renal,N
85,6,Renal impairment,Renal failure and impairment,Renal disorders (excl nephropathies),Renal,N
85,7,Vomiting,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
86,1,Myocardial infarction,Ischaemic coronary artery disorders,Coronary artery disorders,Card,N
87,1,Myocardial infarction,Ischaemic coronary artery disorders,Coronary artery disorders,Card,N
88,1,Cerebrovascular accident,Central nervous system haemorrhages and cerebrovascular accidents,Central nervous system vascular disorders,Nerv,N
89,1,Disease progression,General signs and symptoms NEC,General system disorders NEC,Genrl,Y
90,1,Death,Death and sudden death,Fatal outcomes,Genrl,Y
91,1,Death,Death and sudden death,Fatal outcomes,Genrl,Y
92,1,Cerebrovascular accident,Central nervous system haemorrhages and cerebrovascular accidents,Central nervous system vascular disorders,Nerv,N
93,1,Cerebrovascular accident,Central nervous system haemorrhages and cerebrovascular accidents,Central nervous system vascular disorders,Nerv,N
94,1,Death,Death and sudden death,Fatal outcomes,Genrl,Y
95,1,Peripheral ischaemia,"Peripheral vasoconstriction, necrosis and vascular insufficiency","Arteriosclerosis, stenosis, vascular insufficiency and necrosis",Vasc,N
96,1,Disease progression,General signs and symptoms NEC,General system disorders NEC,Genrl,Y
96,2,Pneumonia,Lower respiratory tract and lung infections,Infections - pathogen unspecified,Infec,N
96,3,Respiratory failure,Respiratory failures (excl neonatal),Respiratory disorders NEC,Resp,N
97,1,Death,Death and sudden death,Fatal outcomes,Genrl,Y
98,1,Disease progression,General signs and symptoms NEC,General system disorders NEC,Genrl,Y
99,1,Death,Death and sudden death,Fatal outcomes,Genrl,Y
100,1,Fatigue,Asthenic conditions,General system disorders NEC,Genrl,N
100,2,Hepatotoxicity,Hepatocellular damage and hepatitis NEC,Hepatic and hepatobiliary disorders,Hepat,N
100,3,Malaise,Asthenic conditions,General system disorders NEC,Genrl,N
101,1,Decreased appetite,Appetite disorders,Appetite and general nutritional disorders,Metab,N
101,2,Diarrhoea,Diarrhoea (excl infective),Gastrointestinal motility and defaecation conditions,Gastr,N
101,3,Lethargy,Disturbances in consciousness NEC,Neurological disorders NEC,Nerv,N
101,4,Lung carcinoma cell type unspecified recurrent,Respiratory tract and pleural neoplasms malignant cell type unspecified NEC,Respiratory and mediastinal neoplasms malignant and unspecified,Neopl,N
101,5,Lymphadenopathy mediastinal,Lymphatic system disorders NEC,"Spleen, lymphatic and reticuloendothelial system disorders",Blood,N
101,6,Performance status decreased,General signs and symptoms NEC,General system disorders NEC,Genrl,N
101,7,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
102,1,Disease progression,General signs and symptoms NEC,General system disorders NEC,Genrl,N
102,2,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
102,3,Fatigue,Asthenic conditions,General system disorders NEC,Genrl,N
102,4,Transient ischaemic attack,Transient cerebrovascular events,Central nervous system vascular disorders,Nerv,N
103,1,Posterior reversible encephalopathy syndrome,Encephalopathies NEC,Encephalopathies,Nerv,N
104,1,Pulmonary embolism,Pulmonary thrombotic and embolic conditions,Pulmonary vascular disorders,Resp,N
105,1,Hepatitis,Hepatocellular damage and hepatitis NEC,Hepatic and hepatobiliary disorders,Hepat,N
106,1,Pulmonary embolism,Pulmonary thrombotic and embolic conditions,Pulmonary vascular disorders,Resp,N
107,1,Diarrhoea,Diarrhoea (excl infective),Gastrointestinal motility and defaecation conditions,Gastr,N
107,2,Disease progression,General signs and symptoms NEC,General system disorders NEC,Genrl,N
107,3,General physical health deterioration,General signs and symptoms NEC,General system disorders NEC,Genrl,N
107,4,Oral pain,Oral soft tissue signs and symptoms,Oral soft tissue conditions,Gastr,N
107,5,Palliative care,Therapeutic procedures NEC,Therapeutic procedures and supportive care NEC,Surg,N
107,6,Pleural effusion,Pneumothorax and pleural effusions NEC,Pleural disorders,Resp,N
107,7,Thoracic cavity drainage,Chest wall and mediastinal therapeutic procedures,Respiratory tract therapeutic procedures,Surg,N
107,8,Toxicity to various agents,Poisoning and toxicity,"Exposures, chemical injuries and poisoning",Inj&P,N
108,1,Pneumothorax,Pneumothorax and pleural effusions NEC,Pleural disorders,Resp,N
109,1,Pneumothorax,Pneumothorax and pleural effusions NEC,Pleural disorders,Resp,N
110,1,Pneumothorax,Pneumothorax and pleural effusions NEC,Pleural disorders,Resp,N
111,1,Haemoptysis,Coughing and associated symptoms,Respiratory disorders NEC,Resp,N
112,1,Cardiac failure,Heart failures NEC,Heart failures,Card,N
113,1,Cardiotoxicity,Cardiac disorders NEC,"Cardiac disorders, signs and symptoms NEC",Card,N
114,1,Asthenia,Asthenic conditions,General system disorders NEC,Genrl,N
114,2,Drug-induced liver injury,Hepatocellular damage and hepatitis NEC,Hepatic and hepatobiliary disorders,Hepat,N
114,3,Fatigue,Asthenic conditions,General system disorders NEC,Genrl,N
115,1,Jaundice,Cholestasis and jaundice,Hepatic and hepatobiliary disorders,Hepat,N
115,2,Liver function test abnormal,Hepatobiliary function diagnostic procedures,Hepatobiliary investigations,Inv,N
116,1,Blood bilirubin increased,Hepatobiliary function diagnostic procedures,Hepatobiliary investigations,Inv,N
116,2,Hepatic function abnormal,Hepatic enzymes and function abnormalities,Hepatic and hepatobiliary disorders,Hepat,N
116,3,Hyperbilirubinaemia,Cholestasis and jaundice,Hepatic and hepatobiliary disorders,Hepat,N
117,1,Lower respiratory tract infection,Lower respiratory tract and lung infections,Infections - pathogen unspecified,Infec,N
118,1,Pneumonia,Lower respiratory tract and lung infections,Infections - pathogen unspecified,Infec,Y
119,1,Neoplasm progression,Neoplasms unspecified malignancy and site unspecified NEC,Miscellaneous and site unspecified neoplasms malignant and unspecified,Neopl,N
120,1,Blood pressure fluctuation,Blood pressure disorders NEC,Decreased and nonspecific blood pressure disorders and shock,Vasc,N
120,2,Hypertension,Vascular hypertensive disorders NEC,Vascular hypertensive disorders,Vasc,N
120,3,Sleep disorder,Sleep disorders NEC,Sleep disorders and disturbances,Psych,N
121,1,Cardiac failure acute,Heart failures NEC,Heart failures,Card,N
121,2,Dehydration,Total fluid volume decreased,Electrolyte and fluid balance conditions,Metab,N
121,3,Dyspnoea,Breathing abnormalities,Respiratory disorders NEC,Resp,N
121,4,Fatigue,Asthenic conditions,General system disorders NEC,Genrl,N
121,5,Malaise,Asthenic conditions,General system disorders NEC,Genrl,N
121,6,Pleural effusion,Pneumothorax and pleural effusions NEC,Pleural disorders,Resp,N
122,1,Alopecia,Alopecias,Skin appendage conditions,Skin,N
122,2,Aphasia,Cortical dysfunction NEC,Neurological disorders NEC,Nerv,N
122,3,Arthralgia,Joint related signs and symptoms,Joint disorders,Musc,N
122,4,Asthenia,Asthenic conditions,General system disorders NEC,Genrl,N
122,5,Back pain,Musculoskeletal and connective tissue pain and discomfort,Musculoskeletal and connective tissue disorders NEC,Musc,N
122,6,Blood urine present,Urinalysis NEC,Renal and urinary tract investigations and urinalyses,Inv,N
122,7,Constipation,Gastrointestinal atonic and hypomotility disorders NEC,Gastrointestinal motility and defaecation conditions,Gastr,N
122,8,Decreased appetite,Appetite disorders,Appetite and general nutritional disorders,Metab,N
122,9,Diarrhoea,Diarrhoea (excl infective),Gastrointestinal motility and defaecation conditions,Gastr,N
122,10,Dry mouth,Oral dryness and saliva altered,Salivary gland conditions,Gastr,N
122,11,Dry skin,Dermal and epidermal conditions NEC,Epidermal and dermal conditions,Skin,N
122,12,Dyspnoea,Breathing abnormalities,Respiratory disorders NEC,Resp,N
122,13,Epistaxis,Nasal disorders NEC,Upper respiratory tract disorders (excl infections),Resp,N
122,14,Fatigue,Asthenic conditions,General system disorders NEC,Genrl,N
122,15,Gait inability,Gait disturbances,General system disorders NEC,Genrl,N
122,16,Haemoglobin decreased,Red blood cell analyses,Haematology investigations (incl blood groups),Inv,N
122,17,Headache,Headaches NEC,Headaches,Nerv,N
122,18,Hypertension,Vascular hypertensive disorders NEC,Vascular hypertensive disorders,Vasc,N
122,19,Hypophagia,Appetite disorders,Appetite and general nutritional disorders,Metab,N
122,20,Insomnia,Disturbances in initiating and maintaining sleep,Sleep disorders and disturbances,Psych,N
122,21,Myalgia,Muscle pains,Muscle disorders,Musc,N
122,22,Nausea,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
122,23,Pain in extremity,Musculoskeletal and connective tissue pain and discomfort,Musculoskeletal and connective tissue disorders NEC,Musc,N
122,24,Pelvic pain,Reproductive tract signs and symptoms NEC,Reproductive tract disorders NEC,Repro,N
122,25,Platelet count decreased,Platelet analyses,Haematology investigations (incl blood groups),Inv,N
122,26,Protein urine present,Urinalysis NEC,Renal and urinary tract investigations and urinalyses,Inv,N
122,27,Rhinorrhoea,Upper respiratory tract signs and symptoms,Respiratory tract signs and symptoms,Resp,N
122,28,Sleep disorder,Sleep disorders NEC,Sleep disorders and disturbances,Psych,N
122,29,Taste disorder,Sensory abnormalities NEC,Neurological disorders NEC,Nerv,N
122,30,Vomiting,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
122,31,Weight decreased,Physical examination procedures and organ system status,Physical examination and organ system status topics,Inv,N
123,1,Angiopathy,Non-site specific vascular disorders NEC,Vascular disorders NEC,Vasc,N
123,2,Encephalopathy,Encephalopathies NEC,Encephalopathies,Nerv,N
124,1,Intestinal perforation,Intestinal ulcers and perforation NEC,Gastrointestinal ulceration and perforation,Gastr,N
125,1,Malignant neoplasm progression,Neoplasms malignant site unspecified NEC,Miscellaneous and site unspecified neoplasms malignant and unspecified,Neopl,N
126,1,Amenorrhoea,Menstruation with decreased bleeding,Menstrual cycle and uterine bleeding disorders,Repro,N
126,2,Heavy menstrual bleeding,Menstruation with increased bleeding,Menstrual cycle and uterine bleeding disorders,Repro,N
127,1,Fatigue,Asthenic conditions,General system disorders NEC,Genrl,N
127,2,Hypertransaminasaemia,Hepatic enzymes and function abnormalities,Hepatic and hepatobiliary disorders,Hepat,N
127,3,Lymphopenia,Leukopenias NEC,White blood cell disorders,Blood,N
127,4,Monocyte count decreased,White blood cell analyses,Haematology investigations (incl blood groups),Inv,N
127,5,Mouth ulceration,Stomatitis and ulceration,Oral soft tissue conditions,Gastr,N
127,6,Neutropenia,Neutropenias,White blood cell disorders,Blood,N
127,7,Neutropenic sepsis,"Sepsis, bacteraemia, viraemia and fungaemia NEC",Infections - pathogen unspecified,Infec,Y
128,1,Arthralgia,Joint related signs and symptoms,Joint disorders,Musc,N
128,2,Hepatic steatosis,Hepatocellular damage and hepatitis NEC,Hepatic and hepatobiliary disorders,Hepat,N
128,3,Metastases to kidney,Metastases to specified sites,Metastases,Neopl,N
128,4,Metastases to soft tissue,Metastases to specified sites,Metastases,Neopl,N
128,5,Osteolysis,Metabolic bone disorders,Bone disorders (excl congenital and fractures),Musc,N
128,6,Swelling,General signs and symptoms NEC,General system disorders NEC,Genrl,N
129,1,Adrenal mass,Adrenal gland disorders NEC,Adrenal gland disorders,Endo,N
129,2,Embolism arterial,Non-site specific embolism and thrombosis,Embolism and thrombosis,Vasc,N
129,3,Hepatic lesion,Hepatic and hepatobiliary disorders NEC,Hepatic and hepatobiliary disorders,Hepat,N
129,4,Malignant neoplasm progression,Neoplasms malignant site unspecified NEC,Miscellaneous and site unspecified neoplasms malignant and unspecified,Neopl,Y
129,5,Metastases to liver,Metastases to specified sites,Metastases,Neopl,N
129,6,Metastases to lung,Metastases to specified sites,Metastases,Neopl,N
129,7,Metastases to lymph nodes,Metastases to specified sites,Metastases,Neopl,N
129,8,Nephrolithiasis,Renal lithiasis,Urolithiases,Renal,N
129,9,Pancreatic mass,Pancreatic disorders NEC,Exocrine pancreas conditions,Gastr,N
129,10,Pulmonary mass,Respiratory tract disorders NEC,Respiratory disorders NEC,Resp,N
129,11,Renal cyst,Renal neoplasms,Renal disorders (excl nephropathies),Renal,N
129,12,Renal mass,Renal disorders NEC,Renal disorders (excl nephropathies),Renal,N
130,1,Cardiac failure,Heart failures NEC,Heart failures,Card,N
130,2,Dyspnoea,Breathing abnormalities,Respiratory disorders NEC,Resp,N
130,3,Liver function test abnormal,Hepatobiliary function diagnostic procedures,Hepatobiliary investigations,Inv,N
131,1,Osteonecrosis of jaw,Bone disorders NEC,Bone disorders (excl congenital and fractures),Musc,N
131,2,Pain in jaw,Bone related signs and symptoms,Bone disorders (excl congenital and fractures),Musc,N
132,1,Death,Death and sudden death,Fatal outcomes,Genrl,Y
133,1,Hepatotoxicity,Hepatocellular damage and hepatitis NEC,Hepatic and hepatobiliary disorders,Hepat,Y
134,1,Blood pressure increased,Vascular tests NEC (incl blood pressure),Cardiac and vascular investigations (excl enzyme tests),Inv,N
134,2,Diarrhoea,Diarrhoea (excl infective),Gastrointestinal motility and defaecation conditions,Gastr,N
134,3,Groin pain,Soft tissue disorders NEC,Musculoskeletal and connective tissue disorders NEC,Musc,N
134,4,Lethargy,Disturbances in consciousness NEC,Neurological disorders NEC,Nerv,N
134,5,Paraesthesia,Paraesthesias and dysaesthesias,Neurological disorders NEC,Nerv,N
135,1,Anaemia,Anaemias NEC,Anaemias nonhaemolytic and marrow depression,Blood,N
135,2,Blood creatinine increased,Renal function analyses,Renal and urinary tract investigations and urinalyses,Inv,N
135,3,Blood potassium increased,Mineral and electrolyte analyses,"Water, electrolyte and mineral investigations",Inv,N
135,4,Blood pressure systolic increased,Vascular tests NEC (incl blood pressure),Cardiac and vascular investigations (excl enzyme tests),Inv,N
135,5,Blood thyroid stimulating hormone increased,Pituitary analyses anterior,Endocrine investigations (incl sex hormones),Inv,N
135,6,Constipation,Gastrointestinal atonic and hypomotility disorders NEC,Gastrointestinal motility and defaecation conditions,Gastr,N
135,7,Dehydration,Total fluid volume decreased,Electrolyte and fluid balance conditions,Metab,N
135,8,Diarrhoea,Diarrhoea (excl infective),Gastrointestinal motility and defaecation conditions,Gastr,N
135,9,Lethargy,Disturbances in consciousness NEC,Neurological disorders NEC,Nerv,N
135,10,Leukopenia,Leukopenias NEC,White blood cell disorders,Blood,N
135,11,Neutropenia,Neutropenias,White blood cell disorders,Blood,N
135,12,Oral candidiasis,Candida infections,Fungal infectious disorders,Infec,N
135,13,Proteinuria,Urinary abnormalities,Urinary tract signs and symptoms,Renal,N
135,14,Stomatitis,Stomatitis and ulceration,Oral soft tissue conditions,Gastr,N
135,15,Taste disorder,Sensory abnormalities NEC,Neurological disorders NEC,Nerv,N
135,16,Weight decreased,Physical examination procedures and organ system status,Physical examination and organ system status topics,Inv,N
136,1,Acute sinusitis,Upper respiratory tract infections,Infections - pathogen unspecified,Infec,N
136,2,Paranasal sinus hypersecretion,Paranasal sinus disorders (excl infections and neoplasms),Upper respiratory tract disorders (excl infections),Resp,N
136,3,Sinus pain,Upper respiratory tract signs and symptoms,Respiratory tract signs and symptoms,Resp,N
136,4,Upper-airway cough syndrome,Upper respiratory tract signs and symptoms,Respiratory tract signs and symptoms,Resp,N
137,1,Skin infection,Skin structures and soft tissue infections,Infections - pathogen unspecified,Infec,N
137,2,Skin lesion,Dermal and epidermal conditions NEC,Epidermal and dermal conditions,Skin,N
137,3,Wound,Non-site specific injuries NEC,Injuries NEC,Inj&P,N
138,1,Tumour haemorrhage,Oncologic complications and emergencies,Neoplasm related morbidities,Neopl,N
139,1,Ageusia,Sensory abnormalities NEC,Neurological disorders NEC,Nerv,N
139,2,Balance disorder,Coordination and balance disturbances,Neurological disorders NEC,Nerv,N
139,3,Contusion,Skin injuries NEC,Injuries NEC,Inj&P,N
139,4,Decreased appetite,Appetite disorders,Appetite and general nutritional disorders,Metab,N
139,5,Diarrhoea,Diarrhoea (excl infective),Gastrointestinal motility and defaecation conditions,Gastr,N
139,6,Dizziness postural,Neurological signs and symptoms NEC,Neurological disorders NEC,Nerv,N
139,7,Fall,Non-site specific injuries NEC,Injuries NEC,Inj&P,N
139,8,Fatigue,Asthenic conditions,General system disorders NEC,Genrl,N
139,9,Fluid retention,Total fluid volume increased,Electrolyte and fluid balance conditions,Metab,N
139,10,Headache,Headaches NEC,Headaches,Nerv,N
139,11,Hepatotoxicity,Hepatocellular damage and hepatitis NEC,Hepatic and hepatobiliary disorders,Hepat,N
139,12,Hypertension,Vascular hypertensive disorders NEC,Vascular hypertensive disorders,Vasc,N
139,13,Hypertransaminasaemia,Hepatic enzymes and function abnormalities,Hepatic and hepatobiliary disorders,Hepat,N
139,14,Injury,Non-site specific injuries NEC,Injuries NEC,Inj&P,N
139,15,Lethargy,Disturbances in consciousness NEC,Neurological disorders NEC,Nerv,N
139,16,Lower respiratory tract infection,Lower respiratory tract and lung infections,Infections - pathogen unspecified,Infec,N
139,17,Malignant neoplasm progression,Neoplasms malignant site unspecified NEC,Miscellaneous and site unspecified neoplasms malignant and unspecified,Neopl,N
139,18,Metastases to bone,Metastases to specified sites,Metastases,Neopl,N
139,19,Metastases to central nervous system,Metastases to specified sites,Metastases,Neopl,N
139,20,Metastases to liver,Metastases to specified sites,Metastases,Neopl,N
139,21,Metastases to lung,Metastases to specified sites,Metastases,Neopl,N
139,22,Metastatic renal cell carcinoma,Renal neoplasms malignant,Renal and urinary tract neoplasms malignant and unspecified,Neopl,Y
139,23,Muscular weakness,Muscle weakness conditions,Muscle disorders,Musc,N
139,24,Myopathy,Myopathies,Muscle disorders,Musc,N
139,25,Nausea,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
139,26,Oral candidiasis,Candida infections,Fungal infectious disorders,Infec,N
139,27,Pleural effusion,Pneumothorax and pleural effusions NEC,Pleural disorders,Resp,N
139,28,Quality of life decreased,Investigations NEC,"Investigations, imaging and histopathology procedures NEC",Inv,N
139,29,Skin toxicity,Dermal and epidermal conditions NEC,Epidermal and dermal conditions,Skin,N
139,30,Taste disorder,Sensory abnormalities NEC,Neurological disorders NEC,Nerv,N
139,31,Vomiting,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
139,32,Weight decreased,Physical examination procedures and organ system status,Physical examination and organ system status topics,Inv,N
139,33,Wound infection,Infections NEC,Infections - pathogen unspecified,Infec,N
140,1,Epistaxis,Nasal disorders NEC,Upper respiratory tract disorders (excl infections),Resp,N
141,1,Metastases to heart,Metastases to specified sites,Metastases,Neopl,Y
141,2,Metastases to lung,Metastases to specified sites,Metastases,Neopl,N
142,1,Dehydration,Total fluid volume decreased,Electrolyte and fluid balance conditions,Metab,N
142,2,Feeding disorder,General nutritional disorders NEC,Appetite and general nutritional disorders,Metab,N
143,1,Cerebrovascular accident,Central nervous system haemorrhages and cerebrovascular accidents,Central nervous system vascular disorders,Nerv,N
144,1,Drug-induced liver injury,Hepatocellular damage and hepatitis NEC,Hepatic and hepatobiliary disorders,Hepat,N
144,2,Vomiting,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
145,1,Blood pressure increased,Vascular tests NEC (incl blood pressure),Cardiac and vascular investigations (excl enzyme tests),Inv,N
145,2,Diarrhoea,Diarrhoea (excl infective),Gastrointestinal motility and defaecation conditions,Gastr,N
145,3,Intervertebral disc disorder,Intervertebral disc disorders NEC,Musculoskeletal and connective tissue deformities (incl intervertebral disc disorders),Musc,N
145,4,Liver function test abnormal,Hepatobiliary function diagnostic procedures,Hepatobiliary investigations,Inv,N
145,5,Platelet count decreased,Platelet analyses,Haematology investigations (incl blood groups),Inv,N
145,6,Platelet count decreased,Platelet analyses,Haematology investigations (incl blood groups),Inv,N
146,1,Blood albumin increased,Protein analyses NEC,Protein and chemistry analyses NEC,Inv,N
146,2,Blood calcium increased,Mineral and electrolyte analyses,"Water, electrolyte and mineral investigations",Inv,N
146,3,Chest wall mass,Musculoskeletal and connective tissue conditions NEC,Musculoskeletal and connective tissue disorders NEC,Musc,N
146,4,Fatigue,Asthenic conditions,General system disorders NEC,Genrl,N
146,5,Hypertension,Vascular hypertensive disorders NEC,Vascular hypertensive disorders,Vasc,N
146,6,Palmar-plantar erythrodysaesthesia syndrome,Dermatitis ascribed to specific agent,Epidermal and dermal conditions,Skin,N
146,7,Urine protein/creatinine ratio increased,Renal function analyses,Renal and urinary tract investigations and urinalyses,Inv,N
147,1,Decreased appetite,Appetite disorders,Appetite and general nutritional disorders,Metab,N
147,2,Drug intolerance,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
147,3,Fatigue,Asthenic conditions,General system disorders NEC,Genrl,N
147,4,Metastases to central nervous system,Metastases to specified sites,Metastases,Neopl,Y
148,1,Hypertension,Vascular hypertensive disorders NEC,Vascular hypertensive disorders,Vasc,N
148,2,Palmar-plantar erythrodysaesthesia syndrome,Dermatitis ascribed to specific agent,Epidermal and dermal conditions,Skin,N
148,3,Proteinuria,Urinary abnormalities,Urinary tract signs and symptoms,Renal,N
149,1,Haematuria,Urinary abnormalities,Urinary tract signs and symptoms,Renal,N
149,2,Ischaemic cerebral infarction,Central nervous system haemorrhages and cerebrovascular accidents,Central nervous system vascular disorders,Nerv,N
149,3,Ischaemic stroke,Central nervous system haemorrhages and cerebrovascular accidents,Central nervous system vascular disorders,Nerv,N
149,4,Paraneoplastic syndrome,Paraneoplastic syndromes NEC,Neoplasm related morbidities,Neopl,N
150,1,Myocardial infarction,Ischaemic coronary artery disorders,Coronary artery disorders,Card,N
151,1,Neutropenia,Neutropenias,White blood cell disorders,Blood,N
152,1,Diarrhoea,Diarrhoea (excl infective),Gastrointestinal motility and defaecation conditions,Gastr,N
153,1,Malignant neoplasm progression,Neoplasms malignant site unspecified NEC,Miscellaneous and site unspecified neoplasms malignant and unspecified,Neopl,N
154,1,Back pain,Musculoskeletal and connective tissue pain and discomfort,Musculoskeletal and connective tissue disorders NEC,Musc,N
154,2,Spinal cord infection,Central nervous system and spinal infections,Infections - pathogen unspecified,Infec,N
155,1,Drug-induced liver injury,Hepatocellular damage and hepatitis NEC,Hepatic and hepatobiliary disorders,Hepat,N
155,2,Jaundice,Cholestasis and jaundice,Hepatic and hepatobiliary disorders,Hepat,N
156,1,Arthralgia,Joint related signs and symptoms,Joint disorders,Musc,N
156,2,Blood thyroid stimulating hormone increased,Pituitary analyses anterior,Endocrine investigations (incl sex hormones),Inv,N
156,3,Bone pain,Bone related signs and symptoms,Bone disorders (excl congenital and fractures),Musc,N
156,4,Decreased appetite,Appetite disorders,Appetite and general nutritional disorders,Metab,N
156,5,Diarrhoea,Diarrhoea (excl infective),Gastrointestinal motility and defaecation conditions,Gastr,N
156,6,Diastolic hypertension,Vascular hypertensive disorders NEC,Vascular hypertensive disorders,Vasc,N
156,7,Fatigue,Asthenic conditions,General system disorders NEC,Genrl,N
156,8,Hypertension,Vascular hypertensive disorders NEC,Vascular hypertensive disorders,Vasc,N
156,9,Metastases to lung,Metastases to specified sites,Metastases,Neopl,N
156,10,Mouth ulceration,Stomatitis and ulceration,Oral soft tissue conditions,Gastr,N
156,11,Mucosal inflammation,Mucosal findings abnormal,General system disorders NEC,Genrl,N
156,12,Musculoskeletal stiffness,Musculoskeletal and connective tissue conditions NEC,Musculoskeletal and connective tissue disorders NEC,Musc,N
156,13,Nausea,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
156,14,Oral pain,Oral soft tissue signs and symptoms,Oral soft tissue conditions,Gastr,N
156,15,Palmar-plantar erythrodysaesthesia syndrome,Dermatitis ascribed to specific agent,Epidermal and dermal conditions,Skin,N
156,16,Stomatitis,Stomatitis and ulceration,Oral soft tissue conditions,Gastr,N
157,1,Hepatitis cholestatic,Cholestasis and jaundice,Hepatic and hepatobiliary disorders,Hepat,N
157,2,Jaundice cholestatic,Cholestasis and jaundice,Hepatic and hepatobiliary disorders,Hepat,N
158,1,Alanine aminotransferase increased,Hepatobiliary function diagnostic procedures,Hepatobiliary investigations,Inv,N
159,1,Hepatotoxicity,Hepatocellular damage and hepatitis NEC,Hepatic and hepatobiliary disorders,Hepat,N
160,1,Pyrexia,Febrile disorders,Body temperature conditions,Genrl,N
161,1,Decreased appetite,Appetite disorders,Appetite and general nutritional disorders,Metab,N
161,2,Jaundice,Cholestasis and jaundice,Hepatic and hepatobiliary disorders,Hepat,N
161,3,Liver function test abnormal,Hepatobiliary function diagnostic procedures,Hepatobiliary investigations,Inv,N
161,4,Nausea,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
162,1,Chest discomfort,Pain and discomfort NEC,General system disorders NEC,Genrl,N
162,2,Dyspnoea,Breathing abnormalities,Respiratory disorders NEC,Resp,N
162,3,Interstitial lung disease,Parenchymal lung disorders NEC,Lower respiratory tract disorders (excl obstruction and infection),Resp,N
163,1,Renal failure,Renal failure and impairment,Renal disorders (excl nephropathies),Renal,N
163,2,Tubulointerstitial nephritis,Nephritis NEC,Nephropathies,Renal,N
164,1,Arthralgia,Joint related signs and symptoms,Joint disorders,Musc,N
164,2,Cough,Coughing and associated symptoms,Respiratory disorders NEC,Resp,N
164,3,Dyspnoea,Breathing abnormalities,Respiratory disorders NEC,Resp,N
164,4,Malignant neoplasm progression,Neoplasms malignant site unspecified NEC,Miscellaneous and site unspecified neoplasms malignant and unspecified,Neopl,N
164,5,Metastases to the mediastinum,Metastases to specified sites,Metastases,Neopl,N
165,1,Ageusia,Sensory abnormalities NEC,Neurological disorders NEC,Nerv,N
165,2,Blood thyroid stimulating hormone increased,Pituitary analyses anterior,Endocrine investigations (incl sex hormones),Inv,N
165,3,Diarrhoea,Diarrhoea (excl infective),Gastrointestinal motility and defaecation conditions,Gastr,N
165,4,Diarrhoea,Diarrhoea (excl infective),Gastrointestinal motility and defaecation conditions,Gastr,N
165,5,Diarrhoea,Diarrhoea (excl infective),Gastrointestinal motility and defaecation conditions,Gastr,N
165,6,Dyspepsia,Dyspeptic signs and symptoms,Gastrointestinal signs and symptoms,Gastr,N
165,7,Fatigue,Asthenic conditions,General system disorders NEC,Genrl,N
165,8,Hair colour changes,Pilar disorders NEC,Skin appendage conditions,Skin,N
165,9,Malignant neoplasm progression,Neoplasms malignant site unspecified NEC,Miscellaneous and site unspecified neoplasms malignant and unspecified,Neopl,N
165,10,Musculoskeletal discomfort,Musculoskeletal and connective tissue pain and discomfort,Musculoskeletal and connective tissue disorders NEC,Musc,N
165,11,Nausea,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
165,12,Oral pain,Oral soft tissue signs and symptoms,Oral soft tissue conditions,Gastr,N
165,13,Pain,Pain and discomfort NEC,General system disorders NEC,Genrl,N
165,14,Pain in extremity,Musculoskeletal and connective tissue pain and discomfort,Musculoskeletal and connective tissue disorders NEC,Musc,N
165,15,Skin hypopigmentation,Hypopigmentation disorders,Pigmentation disorders,Skin,N
165,16,Vomiting,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
165,17,Weight decreased,Physical examination procedures and organ system status,Physical examination and organ system status topics,Inv,N
166,1,Interstitial lung disease,Parenchymal lung disorders NEC,Lower respiratory tract disorders (excl obstruction and infection),Resp,Y
166,2,Malignant neoplasm progression,Neoplasms malignant site unspecified NEC,Miscellaneous and site unspecified neoplasms malignant and unspecified,Neopl,N
167,1,Alanine aminotransferase increased,Hepatobiliary function diagnostic procedures,Hepatobiliary investigations,Inv,N
167,2,Death,Death and sudden death,Fatal outcomes,Genrl,Y
167,3,Diarrhoea,Diarrhoea (excl infective),Gastrointestinal motility and defaecation conditions,Gastr,N
167,4,Malaise,Asthenic conditions,General system disorders NEC,Genrl,N
167,5,Nausea,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
167,6,Performance status decreased,General signs and symptoms NEC,General system disorders NEC,Genrl,N
167,7,Renal failure,Renal failure and impairment,Renal disorders (excl nephropathies),Renal,N
168,1,Haematuria,Urinary abnormalities,Urinary tract signs and symptoms,Renal,N
169,1,Ageusia,Sensory abnormalities NEC,Neurological disorders NEC,Nerv,N
169,2,Blood thyroid stimulating hormone increased,Pituitary analyses anterior,Endocrine investigations (incl sex hormones),Inv,N
169,3,Diarrhoea,Diarrhoea (excl infective),Gastrointestinal motility and defaecation conditions,Gastr,N
169,4,Diarrhoea,Diarrhoea (excl infective),Gastrointestinal motility and defaecation conditions,Gastr,N
169,5,Diarrhoea,Diarrhoea (excl infective),Gastrointestinal motility and defaecation conditions,Gastr,N
169,6,Fatigue,Asthenic conditions,General system disorders NEC,Genrl,N
169,7,Flank pain,Musculoskeletal and connective tissue pain and discomfort,Musculoskeletal and connective tissue disorders NEC,Musc,N
169,8,Malignant neoplasm progression,Neoplasms malignant site unspecified NEC,Miscellaneous and site unspecified neoplasms malignant and unspecified,Neopl,Y
169,9,Musculoskeletal discomfort,Musculoskeletal and connective tissue pain and discomfort,Musculoskeletal and connective tissue disorders NEC,Musc,N
169,10,Nausea,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
169,11,Oral pain,Oral soft tissue signs and symptoms,Oral soft tissue conditions,Gastr,N
169,12,Pain in extremity,Musculoskeletal and connective tissue pain and discomfort,Musculoskeletal and connective tissue disorders NEC,Musc,N
169,13,Skin hypopigmentation,Hypopigmentation disorders,Pigmentation disorders,Skin,N
169,14,Vomiting,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
169,15,Weight decreased,Physical examination procedures and organ system status,Physical examination and organ system status topics,Inv,N
170,1,Ulcer,Ulcers NEC,Tissue disorders NEC,Genrl,N
171,1,Depressed mood,Mood alterations with depressive symptoms,Depressed mood disorders and disturbances,Psych,N
171,2,Diarrhoea,Diarrhoea (excl infective),Gastrointestinal motility and defaecation conditions,Gastr,N
171,3,Fatigue,Asthenic conditions,General system disorders NEC,Genrl,N
171,4,Hepatic enzyme increased,Hepatobiliary function diagnostic procedures,Hepatobiliary investigations,Inv,N
171,5,Infection,Infections NEC,Infections - pathogen unspecified,Infec,N
171,6,Mucosal inflammation,Mucosal findings abnormal,General system disorders NEC,Genrl,N
171,7,Nausea,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
171,8,Palmar-plantar erythrodysaesthesia syndrome,Dermatitis ascribed to specific agent,Epidermal and dermal conditions,Skin,N
171,9,Toxicity to various agents,Poisoning and toxicity,"Exposures, chemical injuries and poisoning",Inj&P,N
172,1,Abdominal pain,Gastrointestinal and abdominal pains (excl oral and throat),Gastrointestinal signs and symptoms,Gastr,N
172,2,Blood bilirubin increased,Hepatobiliary function diagnostic procedures,Hepatobiliary investigations,Inv,N
172,3,Blood magnesium decreased,Mineral and electrolyte analyses,"Water, electrolyte and mineral investigations",Inv,N
172,4,Blood pressure increased,Vascular tests NEC (incl blood pressure),Cardiac and vascular investigations (excl enzyme tests),Inv,N
172,5,Decreased appetite,Appetite disorders,Appetite and general nutritional disorders,Metab,N
172,6,Fatigue,Asthenic conditions,General system disorders NEC,Genrl,N
172,7,Weight decreased,Physical examination procedures and organ system status,Physical examination and organ system status topics,Inv,N
173,1,Cough,Coughing and associated symptoms,Respiratory disorders NEC,Resp,N
173,2,Decreased appetite,Appetite disorders,Appetite and general nutritional disorders,Metab,N
173,3,Diarrhoea,Diarrhoea (excl infective),Gastrointestinal motility and defaecation conditions,Gastr,N
173,4,Disease progression,General signs and symptoms NEC,General system disorders NEC,Genrl,N
173,5,Dyspnoea,Breathing abnormalities,Respiratory disorders NEC,Resp,N
173,6,Fatigue,Asthenic conditions,General system disorders NEC,Genrl,N
173,7,Gastrooesophageal reflux disease,Gastrointestinal atonic and hypomotility disorders NEC,Gastrointestinal motility and defaecation conditions,Gastr,N
173,8,Hepatic cyst,Hepatic and hepatobiliary disorders NEC,Hepatic and hepatobiliary disorders,Hepat,N
173,9,Laryngitis,Upper respiratory tract infections,Infections - pathogen unspecified,Infec,N
173,10,Lower respiratory tract infection,Lower respiratory tract and lung infections,Infections - pathogen unspecified,Infec,N
173,11,Lymphadenopathy,Lymphatic system disorders NEC,"Spleen, lymphatic and reticuloendothelial system disorders",Blood,N
173,12,Nausea,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
173,13,Palmar-plantar erythrodysaesthesia syndrome,Dermatitis ascribed to specific agent,Epidermal and dermal conditions,Skin,N
173,14,Taste disorder,Sensory abnormalities NEC,Neurological disorders NEC,Nerv,N
173,15,Weight decreased,Physical examination procedures and organ system status,Physical examination and organ system status topics,Inv,N
174,1,Abdominal discomfort,Gastrointestinal signs and symptoms NEC,Gastrointestinal signs and symptoms,Gastr,N
174,2,Alanine aminotransferase increased,Hepatobiliary function diagnostic procedures,Hepatobiliary investigations,Inv,N
174,3,Blood bilirubin increased,Hepatobiliary function diagnostic procedures,Hepatobiliary investigations,Inv,N
174,4,Chromaturia,Urinary abnormalities,Urinary tract signs and symptoms,Renal,N
174,5,Drug interaction,Interactions,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
174,6,Eye colour change,"Iris and ciliary body structural change, deposit and degeneration","Anterior eye structural change, deposit and degeneration",Eye,N
174,7,Faeces pale,Faecal abnormalities NEC,Gastrointestinal signs and symptoms,Gastr,N
174,8,Jaundice,Cholestasis and jaundice,Hepatic and hepatobiliary disorders,Hepat,N
174,9,Platelet count decreased,Platelet analyses,Haematology investigations (incl blood groups),Inv,N
174,10,Scleral discolouration,"Scleral structural change, deposit and degeneration","Ocular structural change, deposit and degeneration NEC",Eye,N
175,1,Clear cell renal cell carcinoma,Renal neoplasms malignant,Renal and urinary tract neoplasms malignant and unspecified,Neopl,N
175,2,Malignant neoplasm progression,Neoplasms malignant site unspecified NEC,Miscellaneous and site unspecified neoplasms malignant and unspecified,Neopl,N
176,1,Clear cell renal cell carcinoma,Renal neoplasms malignant,Renal and urinary tract neoplasms malignant and unspecified,Neopl,N
176,2,Malignant neoplasm progression,Neoplasms malignant site unspecified NEC,Miscellaneous and site unspecified neoplasms malignant and unspecified,Neopl,N
177,1,Clear cell renal cell carcinoma,Renal neoplasms malignant,Renal and urinary tract neoplasms malignant and unspecified,Neopl,N
177,2,Malignant neoplasm progression,Neoplasms malignant site unspecified NEC,Miscellaneous and site unspecified neoplasms malignant and unspecified,Neopl,N
178,1,Drug interaction,Interactions,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
178,2,Hepatotoxicity,Hepatocellular damage and hepatitis NEC,Hepatic and hepatobiliary disorders,Hepat,N
179,1,Clear cell renal cell carcinoma,Renal neoplasms malignant,Renal and urinary tract neoplasms malignant and unspecified,Neopl,N
179,2,Malignant neoplasm progression,Neoplasms malignant site unspecified NEC,Miscellaneous and site unspecified neoplasms malignant and unspecified,Neopl,N
180,1,Clear cell renal cell carcinoma,Renal neoplasms malignant,Renal and urinary tract neoplasms malignant and unspecified,Neopl,N
180,2,Malignant neoplasm progression,Neoplasms malignant site unspecified NEC,Miscellaneous and site unspecified neoplasms malignant and unspecified,Neopl,N
181,1,Clear cell renal cell carcinoma,Renal neoplasms malignant,Renal and urinary tract neoplasms malignant and unspecified,Neopl,N
181,2,Malignant neoplasm progression,Neoplasms malignant site unspecified NEC,Miscellaneous and site unspecified neoplasms malignant and unspecified,Neopl,N
182,1,Clear cell renal cell carcinoma,Renal neoplasms malignant,Renal and urinary tract neoplasms malignant and unspecified,Neopl,N
182,2,Malignant neoplasm progression,Neoplasms malignant site unspecified NEC,Miscellaneous and site unspecified neoplasms malignant and unspecified,Neopl,N
183,1,Clear cell renal cell carcinoma,Renal neoplasms malignant,Renal and urinary tract neoplasms malignant and unspecified,Neopl,N
183,2,Malignant neoplasm progression,Neoplasms malignant site unspecified NEC,Miscellaneous and site unspecified neoplasms malignant and unspecified,Neopl,N
184,1,Blood pressure systolic increased,Vascular tests NEC (incl blood pressure),Cardiac and vascular investigations (excl enzyme tests),Inv,N
184,2,Blood thyroid stimulating hormone increased,Pituitary analyses anterior,Endocrine investigations (incl sex hormones),Inv,N
185,1,Disease progression,General signs and symptoms NEC,General system disorders NEC,Genrl,N
185,2,Fatigue,Asthenic conditions,General system disorders NEC,Genrl,N
185,3,Hypertension,Vascular hypertensive disorders NEC,Vascular hypertensive disorders,Vasc,N
186,1,Hepatitis B reactivation,Hepatitis virus infections,Viral infectious disorders,Infec,N
187,1,Chest pain,Pain and discomfort NEC,General system disorders NEC,Genrl,N
187,2,Dyspnoea,Breathing abnormalities,Respiratory disorders NEC,Resp,N
187,3,Nausea,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
187,4,Stress cardiomyopathy,Cardiomyopathies,Myocardial disorders,Card,N
187,5,Vomiting,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
188,1,Abdominal pain upper,Gastrointestinal and abdominal pains (excl oral and throat),Gastrointestinal signs and symptoms,Gastr,N
188,2,Diarrhoea,Diarrhoea (excl infective),Gastrointestinal motility and defaecation conditions,Gastr,N
188,3,Hair colour changes,Pilar disorders NEC,Skin appendage conditions,Skin,N
188,4,Malignant neoplasm progression,Neoplasms malignant site unspecified NEC,Miscellaneous and site unspecified neoplasms malignant and unspecified,Neopl,N
188,5,Nausea,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
189,1,Generalised tonic-clonic seizure,Generalised tonic-clonic seizures,Seizures (incl subtypes),Nerv,N
189,2,Hypertension,Vascular hypertensive disorders NEC,Vascular hypertensive disorders,Vasc,N
189,3,Posterior reversible encephalopathy syndrome,Encephalopathies NEC,Encephalopathies,Nerv,N
190,1,Disease progression,General signs and symptoms NEC,General system disorders NEC,Genrl,N
190,2,Hepatic lesion,Hepatic and hepatobiliary disorders NEC,Hepatic and hepatobiliary disorders,Hepat,N
190,3,Metastases to bone,Metastases to specified sites,Metastases,Neopl,N
190,4,Metastases to lung,Metastases to specified sites,Metastases,Neopl,N
191,1,Abdominal pain,Gastrointestinal and abdominal pains (excl oral and throat),Gastrointestinal signs and symptoms,Gastr,N
191,2,Disease progression,General signs and symptoms NEC,General system disorders NEC,Genrl,N
191,3,Solar lentigo,Hyperpigmentation disorders,Pigmentation disorders,Skin,N
192,1,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
192,2,Malignant neoplasm progression,Neoplasms malignant site unspecified NEC,Miscellaneous and site unspecified neoplasms malignant and unspecified,Neopl,N
193,1,Disease progression,General signs and symptoms NEC,General system disorders NEC,Genrl,N
194,1,Trismus,Muscle tone abnormalities,Muscle disorders,Musc,N
195,1,Disease progression,General signs and symptoms NEC,General system disorders NEC,Genrl,N
196,1,Desmoid tumour,Soft tissue neoplasms benign NEC,Soft tissue neoplasms benign,Neopl,N
196,2,Desmoid tumour,Soft tissue neoplasms benign NEC,Soft tissue neoplasms benign,Neopl,N
196,3,Malignant neoplasm progression,Neoplasms malignant site unspecified NEC,Miscellaneous and site unspecified neoplasms malignant and unspecified,Neopl,N
197,1,Hypertension,Vascular hypertensive disorders NEC,Vascular hypertensive disorders,Vasc,N
197,2,Toxicity to various agents,Poisoning and toxicity,"Exposures, chemical injuries and poisoning",Inj&P,N
198,1,Tumour pain,Oncologic complications and emergencies,Neoplasm related morbidities,Neopl,N
199,1,Liver function test increased,Hepatobiliary function diagnostic procedures,Hepatobiliary investigations,Inv,N
199,2,Transaminases increased,Hepatobiliary function diagnostic procedures,Hepatobiliary investigations,Inv,N
200,1,Gastrointestinal haemorrhage,Non-site specific gastrointestinal haemorrhages,Gastrointestinal haemorrhages NEC,Gastr,N
201,1,Agitation,Anxiety symptoms,Anxiety disorders and symptoms,Psych,N
201,2,Aphasia,Cortical dysfunction NEC,Neurological disorders NEC,Nerv,N
201,3,Confusional state,Confusion and disorientation,Deliria (incl confusion),Psych,N
201,4,Headache,Headaches NEC,Headaches,Nerv,N
201,5,Hypertension,Vascular hypertensive disorders NEC,Vascular hypertensive disorders,Vasc,N
201,6,Photophobia,Ocular sensation disorders,Ocular sensory symptoms NEC,Eye,N
201,7,Posterior reversible encephalopathy syndrome,Encephalopathies NEC,Encephalopathies,Nerv,N
201,8,Respiratory arrest,Breathing abnormalities,Respiratory disorders NEC,Resp,N
201,9,Seizure,Seizures and seizure disorders NEC,Seizures (incl subtypes),Nerv,N
202,1,Malignant neoplasm progression,Neoplasms malignant site unspecified NEC,Miscellaneous and site unspecified neoplasms malignant and unspecified,Neopl,Y
202,2,Renal cell carcinoma,Renal neoplasms malignant,Renal and urinary tract neoplasms malignant and unspecified,Neopl,N
203,1,Ingrowing nail,Nail and nail bed conditions (excl infections and infestations),Skin appendage conditions,Skin,N
204,1,Blood bilirubin increased,Hepatobiliary function diagnostic procedures,Hepatobiliary investigations,Inv,N
204,2,Hepatic failure,Hepatic failure and associated disorders,Hepatic and hepatobiliary disorders,Hepat,N
205,1,Posterior reversible encephalopathy syndrome,Encephalopathies NEC,Encephalopathies,Nerv,N
206,1,Hepatotoxicity,Hepatocellular damage and hepatitis NEC,Hepatic and hepatobiliary disorders,Hepat,N
207,1,Bone marrow tumour cell infiltration,Haematologic neoplasms NEC,Haematopoietic neoplasms (excl leukaemias and lymphomas),Neopl,N
207,2,Subdural haematoma,Cerebral injuries NEC,Injuries NEC,Inj&P,N
207,3,Thrombocytopenia,Thrombocytopenias,Platelet disorders,Blood,N
208,1,Bone marrow tumour cell infiltration,Haematologic neoplasms NEC,Haematopoietic neoplasms (excl leukaemias and lymphomas),Neopl,N
208,2,Subdural haematoma,Cerebral injuries NEC,Injuries NEC,Inj&P,N
208,3,Thrombocytopenia,Thrombocytopenias,Platelet disorders,Blood,N
208,4,Thrombotic microangiopathy,Coagulopathies,Coagulopathies and bleeding diatheses (excl thrombocytopenic),Blood,N
209,1,Diarrhoea,Diarrhoea (excl infective),Gastrointestinal motility and defaecation conditions,Gastr,N
209,2,Illness,General signs and symptoms NEC,General system disorders NEC,Genrl,N
209,3,Renal impairment,Renal failure and impairment,Renal disorders (excl nephropathies),Renal,N
210,1,Abdominal pain,Gastrointestinal and abdominal pains (excl oral and throat),Gastrointestinal signs and symptoms,Gastr,N
210,2,Large intestine perforation,Intestinal ulcers and perforation NEC,Gastrointestinal ulceration and perforation,Gastr,Y
210,3,Sepsis,"Sepsis, bacteraemia, viraemia and fungaemia NEC",Infections - pathogen unspecified,Infec,N
211,1,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
211,2,Feeling abnormal,Feelings and sensations NEC,General system disorders NEC,Genrl,N
211,3,Headache,Headaches NEC,Headaches,Nerv,N
211,4,Hypertension,Vascular hypertensive disorders NEC,Vascular hypertensive disorders,Vasc,N
211,5,Nausea,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
211,6,Vomiting,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
212,1,Chills,Feelings and sensations NEC,General system disorders NEC,Genrl,N
212,2,Cytokine release syndrome,Immune and associated conditions NEC,Immune disorders NEC,Immun,N
212,3,Infection,Infections NEC,Infections - pathogen unspecified,Infec,N
212,4,Pyrexia,Febrile disorders,Body temperature conditions,Genrl,N
212,5,Tumour necrosis,Oncologic complications and emergencies,Neoplasm related morbidities,Neopl,N
213,1,Myocardial infarction,Ischaemic coronary artery disorders,Coronary artery disorders,Card,N
214,1,Disease progression,General signs and symptoms NEC,General system disorders NEC,Genrl,N
215,1,Alanine aminotransferase increased,Hepatobiliary function diagnostic procedures,Hepatobiliary investigations,Inv,N
215,2,Diarrhoea,Diarrhoea (excl infective),Gastrointestinal motility and defaecation conditions,Gastr,N
215,3,Disease progression,General signs and symptoms NEC,General system disorders NEC,Genrl,N
216,1,Diarrhoea,Diarrhoea (excl infective),Gastrointestinal motility and defaecation conditions,Gastr,N
216,2,Disease progression,General signs and symptoms NEC,General system disorders NEC,Genrl,N
216,3,Systolic hypertension,Vascular hypertensive disorders NEC,Vascular hypertensive disorders,Vasc,N
217,1,Hypertension,Vascular hypertensive disorders NEC,Vascular hypertensive disorders,Vasc,N
218,1,Osteonecrosis,Bone disorders NEC,Bone disorders (excl congenital and fractures),Musc,N
219,1,Deep vein thrombosis,Peripheral embolism and thrombosis,Embolism and thrombosis,Vasc,N
219,2,Loss of consciousness,Disturbances in consciousness NEC,Neurological disorders NEC,Nerv,N
219,3,Pulmonary embolism,Pulmonary thrombotic and embolic conditions,Pulmonary vascular disorders,Resp,N
220,1,Drug-induced liver injury,Hepatocellular damage and hepatitis NEC,Hepatic and hepatobiliary disorders,Hepat,N
220,2,Jaundice,Cholestasis and jaundice,Hepatic and hepatobiliary disorders,Hepat,N
221,1,Acute kidney injury,Renal failure and impairment,Renal disorders (excl nephropathies),Renal,N
221,2,Decreased appetite,Appetite disorders,Appetite and general nutritional disorders,Metab,N
221,3,Dizziness,Neurological signs and symptoms NEC,Neurological disorders NEC,Nerv,N
221,4,Dry mouth,Oral dryness and saliva altered,Salivary gland conditions,Gastr,N
221,5,Fatigue,Asthenic conditions,General system disorders NEC,Genrl,N
221,6,General physical health deterioration,General signs and symptoms NEC,General system disorders NEC,Genrl,N
221,7,Nausea,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
221,8,Urinary incontinence,Bladder and urethral symptoms,Urinary tract signs and symptoms,Renal,N
221,9,Vomiting,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
222,1,Abdominal pain,Gastrointestinal and abdominal pains (excl oral and throat),Gastrointestinal signs and symptoms,Gastr,N
222,2,Intestinal perforation,Intestinal ulcers and perforation NEC,Gastrointestinal ulceration and perforation,Gastr,N
223,1,Chondrosarcoma metastatic,Cartilage sarcomas,Skeletal neoplasms malignant and unspecified,Neopl,N
223,2,Hypertension,Vascular hypertensive disorders NEC,Vascular hypertensive disorders,Vasc,N
223,3,Malignant neoplasm progression,Neoplasms malignant site unspecified NEC,Miscellaneous and site unspecified neoplasms malignant and unspecified,Neopl,N
224,1,Diarrhoea,Diarrhoea (excl infective),Gastrointestinal motility and defaecation conditions,Gastr,N
224,2,Fatigue,Asthenic conditions,General system disorders NEC,Genrl,N
224,3,Hypertension,Vascular hypertensive disorders NEC,Vascular hypertensive disorders,Vasc,N
224,4,Myalgia,Muscle pains,Muscle disorders,Musc,N
224,5,Nausea,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
224,6,Tumour pain,Oncologic complications and emergencies,Neoplasm related morbidities,Neopl,N
225,1,Chondrosarcoma metastatic,Cartilage sarcomas,Skeletal neoplasms malignant and unspecified,Neopl,N
225,2,Dry skin,Dermal and epidermal conditions NEC,Epidermal and dermal conditions,Skin,N
225,3,Fatigue,Asthenic conditions,General system disorders NEC,Genrl,N
225,4,Malignant neoplasm progression,Neoplasms malignant site unspecified NEC,Miscellaneous and site unspecified neoplasms malignant and unspecified,Neopl,N
225,5,Nausea,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
225,6,Tumour pain,Oncologic complications and emergencies,Neoplasm related morbidities,Neopl,N
225,7,Visual impairment,Visual impairment and blindness (excl colour blindness),Vision disorders,Eye,N
226,1,Chondrosarcoma metastatic,Cartilage sarcomas,Skeletal neoplasms malignant and unspecified,Neopl,N
226,2,Hypertension,Vascular hypertensive disorders NEC,Vascular hypertensive disorders,Vasc,N
226,3,Malignant neoplasm progression,Neoplasms malignant site unspecified NEC,Miscellaneous and site unspecified neoplasms malignant and unspecified,Neopl,N
226,4,Tumour pain,Oncologic complications and emergencies,Neoplasm related morbidities,Neopl,N
227,1,Eye disorder,Ocular disorders NEC,Eye disorders NEC,Eye,N
227,2,Retinal detachment,"Retinal structural change, deposit and degeneration","Ocular structural change, deposit and degeneration NEC",Eye,N
228,1,Haematotoxicity,Haematological disorders,Haematological disorders NEC,Blood,N
229,1,Hepatotoxicity,Hepatocellular damage and hepatitis NEC,Hepatic and hepatobiliary disorders,Hepat,N
230,1,Acute hepatic failure,Hepatic failure and associated disorders,Hepatic and hepatobiliary disorders,Hepat,N
230,2,Agitation,Anxiety symptoms,Anxiety disorders and symptoms,Psych,N
230,3,Balance disorder,Coordination and balance disturbances,Neurological disorders NEC,Nerv,N
230,4,Cerebral infarction,Central nervous system haemorrhages and cerebrovascular accidents,Central nervous system vascular disorders,Nerv,N
230,5,Decreased appetite,Appetite disorders,Appetite and general nutritional disorders,Metab,N
230,6,Dizziness,Neurological signs and symptoms NEC,Neurological disorders NEC,Nerv,N
230,7,Drug monitoring procedure not performed,Product monitoring errors and issues,Medication errors and other product use errors and issues,Inj&P,N
230,8,Dyspnoea,Breathing abnormalities,Respiratory disorders NEC,Resp,N
230,9,Gallbladder disorder,Gallbladder disorders NEC,Gallbladder disorders,Hepat,N
230,10,Hepatotoxicity,Hepatocellular damage and hepatitis NEC,Hepatic and hepatobiliary disorders,Hepat,Y
230,11,Inhibitory drug interaction,Interactions,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
230,12,Jaundice,Cholestasis and jaundice,Hepatic and hepatobiliary disorders,Hepat,N
230,13,Lactic acidosis,Metabolic acidoses (excl diabetic acidoses),Acid-base disorders,Metab,N
230,14,Malaise,Asthenic conditions,General system disorders NEC,Genrl,N
230,15,Oedema peripheral,Oedema NEC,General system disorders NEC,Genrl,N
230,16,Pneumonia,Lower respiratory tract and lung infections,Infections - pathogen unspecified,Infec,N
230,17,Pulmonary necrosis,Parenchymal lung disorders NEC,Lower respiratory tract disorders (excl obstruction and infection),Resp,N
230,18,Thrombocytopenia,Thrombocytopenias,Platelet disorders,Blood,N
230,19,Tinnitus,Inner ear signs and symptoms,Inner ear and VIIIth cranial nerve disorders,Ear,N
231,1,Proteinuria,Urinary abnormalities,Urinary tract signs and symptoms,Renal,N
231,2,Proteinuria,Urinary abnormalities,Urinary tract signs and symptoms,Renal,N
232,1,Breast mass,Breast disorders NEC,Breast disorders,Repro,N
232,2,Hepatotoxicity,Hepatocellular damage and hepatitis NEC,Hepatic and hepatobiliary disorders,Hepat,N
232,3,Malignant melanoma,Skin melanomas (excl ocular),Skin neoplasms malignant and unspecified,Neopl,N
233,1,Molluscum contagiosum,Molluscum contagiosum viral infections,Viral infectious disorders,Infec,N
233,2,Papule,Dermal and epidermal conditions NEC,Epidermal and dermal conditions,Skin,N
234,1,Alanine aminotransferase increased,Hepatobiliary function diagnostic procedures,Hepatobiliary investigations,Inv,N
234,2,Death,Death and sudden death,Fatal outcomes,Genrl,Y
234,3,Diarrhoea,Diarrhoea (excl infective),Gastrointestinal motility and defaecation conditions,Gastr,N
234,4,Nasopharyngitis,Upper respiratory tract infections,Infections - pathogen unspecified,Infec,N
234,5,Nausea,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
235,1,Neoplasm malignant,Neoplasms malignant site unspecified NEC,Miscellaneous and site unspecified neoplasms malignant and unspecified,Neopl,N
236,1,Decreased appetite,Appetite disorders,Appetite and general nutritional disorders,Metab,N
236,2,Diarrhoea,Diarrhoea (excl infective),Gastrointestinal motility and defaecation conditions,Gastr,N
236,3,Dysgeusia,Sensory abnormalities NEC,Neurological disorders NEC,Nerv,N
236,4,Fatigue,Asthenic conditions,General system disorders NEC,Genrl,N
236,5,Hair colour changes,Pilar disorders NEC,Skin appendage conditions,Skin,N
236,6,Hypertension,Vascular hypertensive disorders NEC,Vascular hypertensive disorders,Vasc,N
236,7,Inappropriate schedule of product administration,Product administration errors and issues,Medication errors and other product use errors and issues,Inj&P,N
236,8,Limb discomfort,Musculoskeletal and connective tissue pain and discomfort,Musculoskeletal and connective tissue disorders NEC,Musc,N
236,9,Nausea,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
236,10,Thyroid disorder,Thyroid disorders NEC,Thyroid gland disorders,Endo,N
237,1,Headache,Headaches NEC,Headaches,Nerv,N
237,2,Hypertension,Vascular hypertensive disorders NEC,Vascular hypertensive disorders,Vasc,N
237,3,Photophobia,Ocular sensation disorders,Ocular sensory symptoms NEC,Eye,N
238,1,Hepatitis,Hepatocellular damage and hepatitis NEC,Hepatic and hepatobiliary disorders,Hepat,N
238,2,Malaise,Asthenic conditions,General system disorders NEC,Genrl,N
239,1,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
239,2,Malignant neoplasm progression,Neoplasms malignant site unspecified NEC,Miscellaneous and site unspecified neoplasms malignant and unspecified,Neopl,N
239,3,Renal cell carcinoma,Renal neoplasms malignant,Renal and urinary tract neoplasms malignant and unspecified,Neopl,N
240,1,Bone marrow disorder,Haematological disorders,Haematological disorders NEC,Blood,N
240,2,Dizziness,Neurological signs and symptoms NEC,Neurological disorders NEC,Nerv,N
240,3,Fatigue,Asthenic conditions,General system disorders NEC,Genrl,N
240,4,Gastrointestinal haemorrhage,Non-site specific gastrointestinal haemorrhages,Gastrointestinal haemorrhages NEC,Gastr,N
240,5,Melaena,Non-site specific gastrointestinal haemorrhages,Gastrointestinal haemorrhages NEC,Gastr,N
240,6,Pancytopenia,Marrow depression and hypoplastic anaemias,Anaemias nonhaemolytic and marrow depression,Blood,N
240,7,Petechiae,Purpura and related conditions,Skin vascular abnormalities,Skin,N
241,1,Cardiac failure,Heart failures NEC,Heart failures,Card,N
242,1,Blood test abnormal,Investigations NEC,"Investigations, imaging and histopathology procedures NEC",Inv,N
242,2,Death,Death and sudden death,Fatal outcomes,Genrl,Y
243,1,Blood creatinine increased,Renal function analyses,Renal and urinary tract investigations and urinalyses,Inv,N
244,1,Malignant neoplasm progression,Neoplasms malignant site unspecified NEC,Miscellaneous and site unspecified neoplasms malignant and unspecified,Neopl,N
244,2,Synovial sarcoma metastatic,Soft tissue sarcomas histology unspecified,Soft tissue neoplasms malignant and unspecified,Neopl,N
245,1,Malignant neoplasm progression,Neoplasms malignant site unspecified NEC,Miscellaneous and site unspecified neoplasms malignant and unspecified,Neopl,N
245,2,Undifferentiated sarcoma,Soft tissue sarcomas histology unspecified,Soft tissue neoplasms malignant and unspecified,Neopl,N
246,1,Headache,Headaches NEC,Headaches,Nerv,N
246,2,Hypertension,Vascular hypertensive disorders NEC,Vascular hypertensive disorders,Vasc,N
246,3,Vomiting,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
247,1,Fatigue,Asthenic conditions,General system disorders NEC,Genrl,N
247,2,Malignant neoplasm progression,Neoplasms malignant site unspecified NEC,Miscellaneous and site unspecified neoplasms malignant and unspecified,Neopl,N
247,3,Quality of life decreased,Investigations NEC,"Investigations, imaging and histopathology procedures NEC",Inv,N
247,4,Renal cell carcinoma,Renal neoplasms malignant,Renal and urinary tract neoplasms malignant and unspecified,Neopl,N
248,1,Hepatotoxicity,Hepatocellular damage and hepatitis NEC,Hepatic and hepatobiliary disorders,Hepat,N
249,1,Hepatotoxicity,Hepatocellular damage and hepatitis NEC,Hepatic and hepatobiliary disorders,Hepat,N
250,1,Mesothelioma,Mesotheliomas malignant and unspecified,Mesotheliomas,Neopl,N
250,2,Pain in extremity,Musculoskeletal and connective tissue pain and discomfort,Musculoskeletal and connective tissue disorders NEC,Musc,N
251,1,Blood test abnormal,Investigations NEC,"Investigations, imaging and histopathology procedures NEC",Inv,N
251,2,Hepatotoxicity,Hepatocellular damage and hepatitis NEC,Hepatic and hepatobiliary disorders,Hepat,N
252,1,Jaundice,Cholestasis and jaundice,Hepatic and hepatobiliary disorders,Hepat,N
252,2,Lethargy,Disturbances in consciousness NEC,Neurological disorders NEC,Nerv,N
252,3,Malaise,Asthenic conditions,General system disorders NEC,Genrl,N
252,4,Pruritus,Pruritus NEC,Epidermal and dermal conditions,Skin,N
253,1,Malignant neoplasm progression,Neoplasms malignant site unspecified NEC,Miscellaneous and site unspecified neoplasms malignant and unspecified,Neopl,N
253,2,Metastatic renal cell carcinoma,Renal neoplasms malignant,Renal and urinary tract neoplasms malignant and unspecified,Neopl,N
254,1,Disease progression,General signs and symptoms NEC,General system disorders NEC,Genrl,N
255,1,Disease progression,General signs and symptoms NEC,General system disorders NEC,Genrl,N
256,1,Disease progression,General signs and symptoms NEC,General system disorders NEC,Genrl,N
257,1,Disease progression,General signs and symptoms NEC,General system disorders NEC,Genrl,N
258,1,Disease progression,General signs and symptoms NEC,General system disorders NEC,Genrl,N
259,1,Disease progression,General signs and symptoms NEC,General system disorders NEC,Genrl,N
260,1,Disease progression,General signs and symptoms NEC,General system disorders NEC,Genrl,N
261,1,Disease progression,General signs and symptoms NEC,General system disorders NEC,Genrl,N
262,1,Disease progression,General signs and symptoms NEC,General system disorders NEC,Genrl,N
263,1,Disease progression,General signs and symptoms NEC,General system disorders NEC,Genrl,N
264,1,Disease progression,General signs and symptoms NEC,General system disorders NEC,Genrl,N
265,1,Disease progression,General signs and symptoms NEC,General system disorders NEC,Genrl,N
266,1,Disease progression,General signs and symptoms NEC,General system disorders NEC,Genrl,N
267,1,Disease progression,General signs and symptoms NEC,General system disorders NEC,Genrl,N
268,1,Autonomic neuropathy,Autonomic nervous system disorders,Neuromuscular disorders,Nerv,N
268,2,Hypoperfusion,Circulatory collapse and shock,Decreased and nonspecific blood pressure disorders and shock,Vasc,N
268,3,Hypotension,Vascular hypotensive disorders,Decreased and nonspecific blood pressure disorders and shock,Vasc,N
268,4,Syncope,Disturbances in consciousness NEC,Neurological disorders NEC,Nerv,N
268,5,Transient ischaemic attack,Transient cerebrovascular events,Central nervous system vascular disorders,Nerv,N
269,1,Disease progression,General signs and symptoms NEC,General system disorders NEC,Genrl,N
270,1,Disease progression,General signs and symptoms NEC,General system disorders NEC,Genrl,N
271,1,Disease progression,General signs and symptoms NEC,General system disorders NEC,Genrl,N
272,1,Malignant neoplasm progression,Neoplasms malignant site unspecified NEC,Miscellaneous and site unspecified neoplasms malignant and unspecified,Neopl,N
272,2,Metastatic renal cell carcinoma,Renal neoplasms malignant,Renal and urinary tract neoplasms malignant and unspecified,Neopl,N
273,1,Hepatotoxicity,Hepatocellular damage and hepatitis NEC,Hepatic and hepatobiliary disorders,Hepat,N
273,2,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
274,1,Disease progression,General signs and symptoms NEC,General system disorders NEC,Genrl,N
275,1,Disease progression,General signs and symptoms NEC,General system disorders NEC,Genrl,N
276,1,Abdominal discomfort,Gastrointestinal signs and symptoms NEC,Gastrointestinal signs and symptoms,Gastr,N
276,2,Alanine aminotransferase decreased,Hepatobiliary function diagnostic procedures,Hepatobiliary investigations,Inv,N
276,3,Blood pressure diastolic increased,Vascular tests NEC (incl blood pressure),Cardiac and vascular investigations (excl enzyme tests),Inv,N
276,4,Constipation,Gastrointestinal atonic and hypomotility disorders NEC,Gastrointestinal motility and defaecation conditions,Gastr,N
276,5,Decreased appetite,Appetite disorders,Appetite and general nutritional disorders,Metab,N
276,6,Diarrhoea,Diarrhoea (excl infective),Gastrointestinal motility and defaecation conditions,Gastr,N
276,7,Fatigue,Asthenic conditions,General system disorders NEC,Genrl,N
276,8,Malignant neoplasm progression,Neoplasms malignant site unspecified NEC,Miscellaneous and site unspecified neoplasms malignant and unspecified,Neopl,N
276,9,Nausea,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
276,10,Nodule,Mass conditions NEC,Tissue disorders NEC,Genrl,N
276,11,Renal cell carcinoma,Renal neoplasms malignant,Renal and urinary tract neoplasms malignant and unspecified,Neopl,N
276,12,Taste disorder,Sensory abnormalities NEC,Neurological disorders NEC,Nerv,N
277,1,Cholecystitis,Cholecystitis and cholelithiasis,Gallbladder disorders,Hepat,N
277,2,Drug intolerance,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
277,3,Gastrointestinal disorder,Gastrointestinal disorders NEC,Gastrointestinal conditions NEC,Gastr,N
277,4,Radiation injury,Radiation injuries,Injuries by physical agents,Inj&P,N
278,1,Abdominal mass,Abdominal findings abnormal,Gastrointestinal signs and symptoms,Gastr,N
278,2,Cerebral infarction,Central nervous system haemorrhages and cerebrovascular accidents,Central nervous system vascular disorders,Nerv,N
278,3,Metastases to liver,Metastases to specified sites,Metastases,Neopl,N
278,4,Monoparesis,Paralysis and paresis (excl cranial nerve),Movement disorders (incl parkinsonism),Nerv,N
279,1,Metastases to liver,Metastases to specified sites,Metastases,Neopl,Y
280,1,Cholecystitis,Cholecystitis and cholelithiasis,Gallbladder disorders,Hepat,N
280,2,Drug intolerance,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
280,3,Gastrointestinal disorder,Gastrointestinal disorders NEC,Gastrointestinal conditions NEC,Gastr,N
280,4,Radiation injury,Radiation injuries,Injuries by physical agents,Inj&P,N
281,1,Cellulitis,Bacterial infections NEC,Bacterial infectious disorders,Infec,N
282,1,Blood pressure increased,Vascular tests NEC (incl blood pressure),Cardiac and vascular investigations (excl enzyme tests),Inv,N
282,2,Oedema peripheral,Oedema NEC,General system disorders NEC,Genrl,N
283,1,Metastases to central nervous system,Metastases to specified sites,Metastases,Neopl,N
283,2,Therapy partial responder,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
284,1,Malignant neoplasm progression,Neoplasms malignant site unspecified NEC,Miscellaneous and site unspecified neoplasms malignant and unspecified,Neopl,N
284,2,Renal cell carcinoma,Renal neoplasms malignant,Renal and urinary tract neoplasms malignant and unspecified,Neopl,N
285,1,Malignant neoplasm progression,Neoplasms malignant site unspecified NEC,Miscellaneous and site unspecified neoplasms malignant and unspecified,Neopl,N
285,2,Renal cell carcinoma,Renal neoplasms malignant,Renal and urinary tract neoplasms malignant and unspecified,Neopl,N
286,1,Intestinal perforation,Intestinal ulcers and perforation NEC,Gastrointestinal ulceration and perforation,Gastr,Y
286,2,Malignant melanoma,Skin melanomas (excl ocular),Skin neoplasms malignant and unspecified,Neopl,N
286,3,Malignant neoplasm progression,Neoplasms malignant site unspecified NEC,Miscellaneous and site unspecified neoplasms malignant and unspecified,Neopl,N
287,1,Neutropenia,Neutropenias,White blood cell disorders,Blood,N
288,1,Disturbance in attention,Mental impairment (excl dementia and memory loss),Mental impairment disorders,Nerv,N
288,2,Fatigue,Asthenic conditions,General system disorders NEC,Genrl,N
288,3,Hair colour changes,Pilar disorders NEC,Skin appendage conditions,Skin,N
288,4,Illness,General signs and symptoms NEC,General system disorders NEC,Genrl,N
288,5,Insomnia,Disturbances in initiating and maintaining sleep,Sleep disorders and disturbances,Psych,N
288,6,Loss of libido,Sexual desire disorders,"Sexual dysfunctions, disturbances and gender identity disorders",Psych,N
288,7,Nausea,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
289,1,Lower respiratory tract infection,Lower respiratory tract and lung infections,Infections - pathogen unspecified,Infec,N
289,2,Malaise,Asthenic conditions,General system disorders NEC,Genrl,N
289,3,Sepsis,"Sepsis, bacteraemia, viraemia and fungaemia NEC",Infections - pathogen unspecified,Infec,N
290,1,Death,Death and sudden death,Fatal outcomes,Genrl,Y
291,1,Asthenia,Asthenic conditions,General system disorders NEC,Genrl,N
291,2,Decreased appetite,Appetite disorders,Appetite and general nutritional disorders,Metab,N
291,3,Diarrhoea,Diarrhoea (excl infective),Gastrointestinal motility and defaecation conditions,Gastr,N
291,4,Fatigue,Asthenic conditions,General system disorders NEC,Genrl,N
291,5,Hepatic lesion,Hepatic and hepatobiliary disorders NEC,Hepatic and hepatobiliary disorders,Hepat,N
291,6,Inflammation,Inflammations,General system disorders NEC,Genrl,N
291,7,Inflammation,Inflammations,General system disorders NEC,Genrl,N
291,8,Lymphadenopathy mediastinal,Lymphatic system disorders NEC,"Spleen, lymphatic and reticuloendothelial system disorders",Blood,N
291,9,Malignant neoplasm progression,Neoplasms malignant site unspecified NEC,Miscellaneous and site unspecified neoplasms malignant and unspecified,Neopl,N
291,10,Metastases to liver,Metastases to specified sites,Metastases,Neopl,N
291,11,Metastases to lung,Metastases to specified sites,Metastases,Neopl,N
291,12,Metastatic renal cell carcinoma,Renal neoplasms malignant,Renal and urinary tract neoplasms malignant and unspecified,Neopl,N
291,13,Nausea,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
291,14,Nausea,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
291,15,Oral pain,Oral soft tissue signs and symptoms,Oral soft tissue conditions,Gastr,N
291,16,Palmar-plantar erythrodysaesthesia syndrome,Dermatitis ascribed to specific agent,Epidermal and dermal conditions,Skin,N
291,17,Postoperative wound infection,Infections NEC,Infections - pathogen unspecified,Infec,N
291,18,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
291,19,Scar,Skin injuries NEC,Injuries NEC,Inj&P,N
291,20,Skin depigmentation,Hypopigmentation disorders,Pigmentation disorders,Skin,N
291,21,Skin infection,Skin structures and soft tissue infections,Infections - pathogen unspecified,Infec,N
291,22,Sunburn,Radiation injuries,Injuries by physical agents,Inj&P,N
291,23,Surgical skin tear,Skin procedural complications,Procedural related injuries and complications NEC,Inj&P,N
291,24,Taste disorder,Sensory abnormalities NEC,Neurological disorders NEC,Nerv,N
291,25,Toxicity to various agents,Poisoning and toxicity,"Exposures, chemical injuries and poisoning",Inj&P,N
291,26,Vomiting,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
291,27,Weight decreased,Physical examination procedures and organ system status,Physical examination and organ system status topics,Inv,N
292,1,Blood bilirubin increased,Hepatobiliary function diagnostic procedures,Hepatobiliary investigations,Inv,N
292,2,Fatigue,Asthenic conditions,General system disorders NEC,Genrl,N
292,3,Liver function test increased,Hepatobiliary function diagnostic procedures,Hepatobiliary investigations,Inv,N
292,4,Nausea,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
292,5,Renal cancer metastatic,Renal neoplasms malignant,Renal and urinary tract neoplasms malignant and unspecified,Neopl,N
293,1,Neutropenia,Neutropenias,White blood cell disorders,Blood,N
294,1,Cerebrovascular accident,Central nervous system haemorrhages and cerebrovascular accidents,Central nervous system vascular disorders,Nerv,N
294,2,Multiple organ dysfunction syndrome,General signs and symptoms NEC,General system disorders NEC,Genrl,Y
295,1,Drug intolerance,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
295,2,Malignant neoplasm progression,Neoplasms malignant site unspecified NEC,Miscellaneous and site unspecified neoplasms malignant and unspecified,Neopl,N
295,3,Renal cell carcinoma,Renal neoplasms malignant,Renal and urinary tract neoplasms malignant and unspecified,Neopl,N
296,1,Hepatotoxicity,Hepatocellular damage and hepatitis NEC,Hepatic and hepatobiliary disorders,Hepat,N
297,1,Infection,Infections NEC,Infections - pathogen unspecified,Infec,N
298,1,Hepatotoxicity,Hepatocellular damage and hepatitis NEC,Hepatic and hepatobiliary disorders,Hepat,N
298,2,Malignant neoplasm progression,Neoplasms malignant site unspecified NEC,Miscellaneous and site unspecified neoplasms malignant and unspecified,Neopl,N
298,3,Renal cell carcinoma,Renal neoplasms malignant,Renal and urinary tract neoplasms malignant and unspecified,Neopl,N
299,1,Death,Death and sudden death,Fatal outcomes,Genrl,Y
299,2,Haemorrhage,Haemorrhages NEC,Vascular haemorrhagic disorders,Vasc,N
300,1,Breast angiosarcoma,Breast and nipple neoplasms malignant,Breast neoplasms malignant and unspecified (incl nipple),Neopl,N
300,2,Confusional state,Confusion and disorientation,Deliria (incl confusion),Psych,N
300,3,Hypertension,Vascular hypertensive disorders NEC,Vascular hypertensive disorders,Vasc,N
300,4,Malignant neoplasm progression,Neoplasms malignant site unspecified NEC,Miscellaneous and site unspecified neoplasms malignant and unspecified,Neopl,N
300,5,Product use in unapproved indication,"Medication errors, product use errors and issues NEC",Medication errors and other product use errors and issues,Inj&P,N
301,1,Myalgia,Muscle pains,Muscle disorders,Musc,N
302,1,Disease progression,General signs and symptoms NEC,General system disorders NEC,Genrl,N
302,2,Eye disorder,Ocular disorders NEC,Eye disorders NEC,Eye,N
302,3,Headache,Headaches NEC,Headaches,Nerv,N
303,1,Decreased appetite,Appetite disorders,Appetite and general nutritional disorders,Metab,N
303,2,Dehydration,Total fluid volume decreased,Electrolyte and fluid balance conditions,Metab,N
303,3,Diarrhoea,Diarrhoea (excl infective),Gastrointestinal motility and defaecation conditions,Gastr,N
303,4,Eastern Cooperative Oncology Group performance status worsened,Physical examination procedures and organ system status,Physical examination and organ system status topics,Inv,N
303,5,Fatigue,Asthenic conditions,General system disorders NEC,Genrl,N
303,6,Orthostatic hypotension,Vascular hypotensive disorders,Decreased and nonspecific blood pressure disorders and shock,Vasc,N
304,1,Dermatitis psoriasiform,Psoriatic conditions,Epidermal and dermal conditions,Skin,N
305,1,Acute myocardial infarction,Ischaemic coronary artery disorders,Coronary artery disorders,Card,N
305,2,Cardiac arrest,Ventricular arrhythmias and cardiac arrest,Cardiac arrhythmias,Card,N
306,1,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
306,2,Endometrial stromal sarcoma,Endometrial neoplasms malignant,Reproductive neoplasms female malignant and unspecified,Neopl,N
306,3,Malignant neoplasm progression,Neoplasms malignant site unspecified NEC,Miscellaneous and site unspecified neoplasms malignant and unspecified,Neopl,N
307,1,Blood urine present,Urinalysis NEC,Renal and urinary tract investigations and urinalyses,Inv,N
307,2,Diarrhoea,Diarrhoea (excl infective),Gastrointestinal motility and defaecation conditions,Gastr,N
307,3,Mouth ulceration,Stomatitis and ulceration,Oral soft tissue conditions,Gastr,N
307,4,Musculoskeletal discomfort,Musculoskeletal and connective tissue pain and discomfort,Musculoskeletal and connective tissue disorders NEC,Musc,N
308,1,Diarrhoea,Diarrhoea (excl infective),Gastrointestinal motility and defaecation conditions,Gastr,N
309,1,Hypertension,Vascular hypertensive disorders NEC,Vascular hypertensive disorders,Vasc,N
310,1,Adverse drug reaction,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
310,2,Neoplasm malignant,Neoplasms malignant site unspecified NEC,Miscellaneous and site unspecified neoplasms malignant and unspecified,Neopl,Y
311,1,Hepatitis B,Hepatitis virus infections,Viral infectious disorders,Infec,N
312,1,Hair colour changes,Pilar disorders NEC,Skin appendage conditions,Skin,N
312,2,Myositis,Muscle infections and inflammations,Muscle disorders,Musc,N
312,3,Periostitis,Bone disorders NEC,Bone disorders (excl congenital and fractures),Musc,N
313,1,Flatulence,"Flatulence, bloating and distension",Gastrointestinal signs and symptoms,Gastr,N
313,2,Muscle spasms,Muscle related signs and symptoms NEC,Muscle disorders,Musc,N
313,3,Nausea,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
314,1,Drug intolerance,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
315,1,Hypertension,Vascular hypertensive disorders NEC,Vascular hypertensive disorders,Vasc,N
316,1,Headache,Headaches NEC,Headaches,Nerv,N
317,1,Infection,Infections NEC,Infections - pathogen unspecified,Infec,N
317,2,Subcutaneous abscess,Skin structures and soft tissue infections,Infections - pathogen unspecified,Infec,N
318,1,Malabsorption,Malabsorption syndromes,Malabsorption conditions,Gastr,N
319,1,Agitation,Anxiety symptoms,Anxiety disorders and symptoms,Psych,N
319,2,Confusional state,Confusion and disorientation,Deliria (incl confusion),Psych,N
319,3,Hypophagia,Appetite disorders,Appetite and general nutritional disorders,Metab,N
319,4,Intestinal perforation,Intestinal ulcers and perforation NEC,Gastrointestinal ulceration and perforation,Gastr,Y
319,5,Pain,Pain and discomfort NEC,General system disorders NEC,Genrl,N
320,1,Hospitalisation,Therapeutic procedures NEC,Therapeutic procedures and supportive care NEC,Surg,N
321,1,COVID-19,Coronavirus infections,Viral infectious disorders,Infec,N
321,2,Renal impairment,Renal failure and impairment,Renal disorders (excl nephropathies),Renal,N
322,1,Abdominal discomfort,Gastrointestinal signs and symptoms NEC,Gastrointestinal signs and symptoms,Gastr,N
322,2,Abdominal pain lower,Gastrointestinal and abdominal pains (excl oral and throat),Gastrointestinal signs and symptoms,Gastr,N
322,3,Diarrhoea,Diarrhoea (excl infective),Gastrointestinal motility and defaecation conditions,Gastr,N
323,1,Aphasia,Cortical dysfunction NEC,Neurological disorders NEC,Nerv,N
324,1,Burning sensation,Paraesthesias and dysaesthesias,Neurological disorders NEC,Nerv,N
324,2,Diarrhoea,Diarrhoea (excl infective),Gastrointestinal motility and defaecation conditions,Gastr,N
324,3,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
324,4,Eating disorder,Eating disorders NEC,Eating disorders and disturbances,Psych,N
324,5,Gastric infection,Abdominal and gastrointestinal infections,Infections - pathogen unspecified,Infec,N
324,6,Headache,Headaches NEC,Headaches,Nerv,N
324,7,Malignant neoplasm progression,Neoplasms malignant site unspecified NEC,Miscellaneous and site unspecified neoplasms malignant and unspecified,Neopl,N
324,8,Nausea,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
324,9,Oral pain,Oral soft tissue signs and symptoms,Oral soft tissue conditions,Gastr,N
324,10,Pain in extremity,Musculoskeletal and connective tissue pain and discomfort,Musculoskeletal and connective tissue disorders NEC,Musc,N
324,11,Paraesthesia,Paraesthesias and dysaesthesias,Neurological disorders NEC,Nerv,N
324,12,Skin exfoliation,Exfoliative conditions,Epidermal and dermal conditions,Skin,N
324,13,Tooth loss,Tooth missing,Dental and gingival conditions,Gastr,N
324,14,Vomiting,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
325,1,Neoplasm recurrence,Neoplasms unspecified malignancy and site unspecified NEC,Miscellaneous and site unspecified neoplasms malignant and unspecified,Neopl,N
326,1,Follicular dendritic cell sarcoma,Histiocytoses,Haematopoietic neoplasms (excl leukaemias and lymphomas),Neopl,N
326,2,Malignant neoplasm progression,Neoplasms malignant site unspecified NEC,Miscellaneous and site unspecified neoplasms malignant and unspecified,Neopl,N
327,1,Cardiac arrest,Ventricular arrhythmias and cardiac arrest,Cardiac arrhythmias,Card,Y
328,1,Hyperkalaemia,Potassium imbalance,Electrolyte and fluid balance conditions,Metab,N
329,1,Hypertension,Vascular hypertensive disorders NEC,Vascular hypertensive disorders,Vasc,N
329,2,Toxicity to various agents,Poisoning and toxicity,"Exposures, chemical injuries and poisoning",Inj&P,N
330,1,Fall,Non-site specific injuries NEC,Injuries NEC,Inj&P,N
331,1,Blood pressure measurement,Vascular tests NEC (incl blood pressure),Cardiac and vascular investigations (excl enzyme tests),Inv,N
